Breast Adenocarcinoma disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

MCID: BRS044 MIFTS: 60	Breast Adenocarcinoma malady Categories: Cancer diseases, Rare diseases, Reproductive diseases
Genes Variations Tissues Related diseases Publications Pathways Drugs Download Expand all tables

Aliases & Classifications for Breast Adenocarcinoma

Sources:
¹¹Disease Ontology, ¹³DISEASES, ²⁷GTR, ⁴⁵NCIt, ⁶⁸UMLS
See all MalaCards sources

Aliases & Descriptions for Breast Adenocarcinoma:

Name: Breast Adenocarcinoma ¹¹ ¹³ ⁶⁸

Adenocarcinoma of Breast ¹¹ ²⁷

Mammary Adenocarcinoma ¹¹ ⁶⁸

Classifications:

MalaCards categories:
Global: Cancer diseases, Rare diseases
Anatomical: Reproductive diseases

See all MalaCards categories (disease lists)

External Ids:

Disease Ontology¹¹ DOID:3458

NCIt⁴⁵ C5214

UMLS⁶⁸ C0858252

Summaries for Breast Adenocarcinoma

Sources:
¹¹Disease Ontology, ³⁶MalaCards
See all MalaCards sources

Disease Ontology:¹¹ A breast carcinoma that originates in the milk ducts and/or lobules (glandular tissue) of the breast.

MalaCards based summary: Breast Adenocarcinoma, also known as adenocarcinoma of breast, is related to hepatocellular carcinoma and prostate cancer. An important gene associated with Breast Adenocarcinoma is PIK3CA (Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha), and among its related pathways are Inhibition of Signaling by Overexpressed EGFR and E-cadherin signaling in keratinocytes. Affiliated tissues include breast, lung and kidney, and related mouse phenotypes are Decreased viability and Synthetic lethal with MLN4924 (a NAE inhibitor).

Related Diseases for Breast Adenocarcinoma

Sources:
²⁰GeneAnalytics, ²¹GeneCards
See all MalaCards sources

Diseases in the Breast Adenocarcinoma family:

Rare Adenocarcinoma of the Breast

Diseases related to Breast Adenocarcinoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 180)

id	Related Disease	Score	Top Affiliating Genes
1	hepatocellular carcinoma	27.1	AKT1, BAX, CASP8, CDKN1A, CYCS, EGF
2	prostate cancer	25.5	AKT1, BAX, CASP8, CDKN1A, CYCS, EGF
3	colorectal cancer	25.4	AKT1, BAX, CASP8, CDKN1A, CYCS, EGF
4	eyelid disease	10.8	ERBB2, ESR1
5	gelatinous ascites	10.8	ERBB2, ESR1
6	kidney pelvis sarcomatoid transitional cell carcinoma	10.8	EGFR, ERBB2
7	fibrogenesis imperfecta ossium	10.8	EGF, ERBB2
8	peptic ulcer disease	10.7	EGFR, TP53
9	cholesteatoma of external ear	10.7	ERBB2, ESR1, TP53
10	cell type benign neoplasm	10.7	ERBB2, ESR1, TP53
11	cartilage cancer	10.7	ERBB2, ESR1, TP53
12	vibratory urticaria	10.7	ERBB2, ESR1, TP53
13	leiomyosarcoma	10.7	ERBB2, ESR1, TP53
14	adenocarcinoma	10.7
15	breast adenoma	10.7	ERBB2, ESR1, TP53
16	nerve fibre bundle defect	10.7	ERBB2, ESR1, TP53
17	vulval paget's disease	10.7	ERBB2, ESR1, TP53
18	animal phobia	10.7	EGFR, ERBB2, TP53
19	progesterone-receptor negative breast cancer	10.7	EGF, ERBB2, ESR1
20	mixed cerebral palsy	10.7	ERBB2, ESR1, TP53
21	glottis verrucous carcinoma	10.7	EGFR, ERBB2, ESR1
22	adenomyosis	10.7	BAX, EGFR, ERBB2
23	bladder colonic type adenocarcinoma	10.7	EGFR, ERBB2, ESR1
24	lung carcinoma in situ	10.7	ERBB2, ESR1, TP53
25	retinal dystrophies primarily involving bruch's membrane	10.7	EGF, ESR1, MMP9
26	malignant giant cell tumor of the tendon sheath	10.7	MMP9, TNFSF11, TP53
27	cystinosis, nephropathic	10.7	ERBB2, TP53
28	distal monosomy 9p	10.7	EGFR, ERBB2, TP53
29	anomalous left coronary artery from the pulmonary artery	10.7	EGFR, ERBB2, ESR1
30	antidepressant or antipsychotic toxicity or dose selection	10.7	MMP9, TNFSF11, TP53
31	pleomorphic carcinoma	10.7	EGFR, ERBB2, ESR1
32	pulpitis	10.7	EGF, MMP9, TGFB1
33	immune system cancer	10.7	ERBB2, ESR1, PARP1
34	mantle cell lymphoma	10.6	EGFR, MMP9, TP53
35	pineal region meningioma	10.6	ERBB2, ESR1, TP53
36	bone squamous cell carcinoma	10.6	MMP9, TNFSF11, TP53
37	orbital lymphangioma	10.6	TGFB1, TNF, TP53
38	gallbladder papillary carcinoma	10.6	MMP9, PARP1, TP53
39	adenosquamous prostate carcinoma	10.6	EGF, PLAU
40	pericardial mesothelioma	10.6	EGF, PLAU, TGFB1
41	scrotal carcinoma	10.6	EGFR, ERBB2, TNFSF11
42	ossifying fibromyxoid tumor	10.6	EGFR, ERBB2
43	hodgkin's granuloma	10.6	EGFR, MMP9, TP53
44	dysgraphia	10.6	EGFR, ERBB2, TP53
45	thymus lymphoma	10.6	EGF, ESR1, TNF
46	brittle bone syndrome lethal type	10.6	CASP8, ERBB2, ESR1, TP53
47	novak syndrome	10.6	EGFR, ERBB2, ESR1, TP53
48	ductal carcinoma in situ	10.6	EGFR, ERBB2, ESR1, TP53
49	actinic keratosis	10.6	EGFR, TNF, TP53
50	fallopian tube mucinous adenocarcinoma	10.6	EGFR, ERBB2, ESR1, TP53

Graphical network of the top 20 diseases related to Breast Adenocarcinoma:

Symptoms & Phenotypes for Breast Adenocarcinoma

Sources:
²⁶GenomeRNAi, ⁴¹MGI
See all MalaCards sources

GenomeRNAi Phenotypes related to Breast Adenocarcinoma according to GeneCards Suite gene sharing:

²⁶

id	Description	GenomeRNAi Source Accession	Score	Top Affiliating Genes
1	Decreased viability	GR00381-A-1	10.2	AKT1, EGFR, ERBB2, ESR1, PIK3CA
2	Synthetic lethal with MLN4924 (a NAE inhibitor)	GR00250-A-1	9.7	AKT1, BAX, CASP8, CDKN1A, TGFB1, TNF
3	Decreased viability with paclitaxel	GR00293-A	9.6	EGFR, ERBB2, TGFB1, EGFR, TGFB1

MGI Mouse Phenotypes related to Breast Adenocarcinoma according to GeneCards Suite gene sharing:

⁴¹ (show all 26)

id	Description	MGI Source Accession	Score	Top Affiliating Genes
1	hearing/vestibular/ear	MP:0005377	9.7	BAX, CDKN1A, EGFR, FOS, PARP1, PLAU
2	no phenotypic analysis	MP:0003012	9.4	CDKN1A, EGFR, ESR1, PARP1, PIK3CA, TNF
3	liver/biliary system	MP:0005370	8.8	AKT1, CASP8, CDKN1A, EGFR, ESR1, NQO1
4	limbs/digits/tail	MP:0005371	8.8	BAX, CDKN1A, CTSK, EGFR, ERBB2, ESR1
5	renal/urinary system	MP:0005367	8.7	BAX, CASP8, CDKN1A, EGFR, ESR1, MMP9
6	vision/eye	MP:0005391	8.5	BAX, CDKN1A, EGF, EGFR, FOS, MMP9
7	craniofacial	MP:0005382	8.5	CDKN1A, CTSK, CYCS, EGFR, ERBB2, FOS
8	embryo	MP:0005380	8.5	AKT1, CASP8, CDKN1A, CYCS, EGFR, ERBB2
9	muscle	MP:0005369	8.3	AKT1, BAX, CASP8, CDKN1A, EGFR, ERBB2
10	digestive/alimentary	MP:0005381	8.3	CDKN1A, CTSK, EGF, EGFR, ERBB2, ESR1
11	respiratory system	MP:0005388	8.2	AKT1, BAX, CASP8, CDKN1A, CTSK, EGFR
12	behavior/neurological	MP:0005386	8.1	AKT1, BAX, CDKN1A, CYCS, ERBB2, ESR1
13	cardiovascular system	MP:0005385	8.0	AKT1, CASP8, CDKN1A, CYCS, EGFR, ERBB2
14	reproductive system	MP:0005389	7.9	AKT1, BAX, CDKN1A, EGF, EGFR, ERBB2
15	neoplasm	MP:0002006	7.9	AKT1, BAX, CASP8, CDKN1A, EGFR, ERBB2
16	adipose tissue	MP:0005375	7.9	AKT1, CDKN1A, CTSK, EGFR, ESR1, NQO1
17	skeleton	MP:0005390	7.8	AKT1, BAX, CDKN1A, CTSK, CYCS, EGFR
18	integument	MP:0010771	7.7	AKT1, CASP8, CDKN1A, EGF, EGFR, ERBB2
19	endocrine/exocrine gland	MP:0005379	7.6	AKT1, BAX, CASP8, CDKN1A, CTSK, CYCS
20	mortality/aging	MP:0010768	7.4	AKT1, BAX, CASP8, CDKN1A, CYCS, EGFR
21	nervous system	MP:0003631	7.3	AKT1, BAX, CASP8, CDKN1A, CTSK, CYCS
22	hematopoietic system	MP:0005397	7.2	AKT1, BAX, CASP8, CDKN1A, CTSK, CYCS
23	cellular	MP:0005384	7.2	AKT1, BAX, CASP8, CDKN1A, CTSK, CYCS
24	homeostasis/metabolism	MP:0005376	7.0	AKT1, BAX, CASP8, CDKN1A, CTSK, EGFR
25	immune system	MP:0005387	6.9	AKT1, BAX, CASP8, CDKN1A, CTSK, CYCS
26	growth/size/body region	MP:0005378	6.7	AKT1, BAX, CASP8, CDKN1A, CTSK, CYCS

Drugs & Therapeutics for Breast Adenocarcinoma

Sources:
¹BitterDB, ⁴ClinicalTrials, ¹⁰DGIdb, ¹⁴DrugBank, ²⁹HMDB, ³³IUPHAR, ⁵⁰Novoseek, ⁵⁶PharmGKB
See all MalaCards sources

Drugs for Breast Adenocarcinoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 387)

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

Fulvestrant

approved, investigational

Phase 3, Phase 2, Phase 1

194

129453-61-8

104741, 17756771

Synonyms:

(7R,13S,17S)-13-methyl-7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol

(7R,8R,9S,13S,14S,17S)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol

(7R,8S,9S,13S,14S,17S)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl) nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol

(7alpha,17beta)-7-{9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl}estra-1,3,5(10)-triene-3,17-diol

129453-61-8

7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)estra-1,3,5(10)-triene-3,17-diol

7alpha-(9-((4,4,5,5,5,-Pentafluoropentyl)sulfinyl)nonyl)estra-1,3,5(10)-triene-3,17beta-diol

7alpha-(9-((4,4,5,5,5-Pentafluoropentyl)sulfinyl)nonyl)estra-1,3,5(10)-triene-3,17beta-diol

7alpha-[9[(4,4,5,5,5-Pentafluropentyl)sulfinyl]nonyl]-estra-1,3,5(10)-triene-3, 17 beta diol

AC-4693

AC1L2XEN

AstraZeneca brand of fulvestrant

BIDD:ER0348

BIDD:PXR0136

C070081

C32H47F5O3S

CCRIS 8741

CHEBI:404798

CHEMBL1358

CID104741

D01161

DB00947

Faslodex

Faslodex (TN)

Faslodex(ICI 182,780)

Faslodex, ICI 182780, Fulvestrant

Fulvestrant

Fulvestrant (JAN/USAN/INN)

Fulvestrant [USAN]

HMS2090N22

HSDB 7658

I06-1109

ICI 182,780

ICI 182,789

ICI-182780

Ici 182780

LS-64781

NCGC00164789-02

NSC719276

S1191_Selleck

UNII-22X328QOC4

ZD 182780

ZD-182780

ZD-9238

ZM 182780

ZM-182780

fulvestrant

nchembio.168-comp5

nchembio.76-comp5

nchembio775-comp4

leucovorin

approved

Phase 3, Phase 2, Phase 1

1089

58-05-9

143, 54575

Synonyms:

(5-formyl-5,6,7,8-tetrahydropteroyl)glutamate

(6R,S)-5-Formyltetrahydrofolate

10-Formyl-7,8-dihydrofolate

10-Formyl-7,8-dihydrofolic acid

5-Formyl-5,6,7,8-tetrahydrofolate

5-Formyl-5,6,7,8-tetrahydrofolic acid

5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid

5-Formyltetrahydrofolate

5-Formyltetrahydrofolic acid

5-Formyltetrahydropteroylglutamate

5-Formyltetrahydropteroylglutamic acid

5-formyltetrahydrofolic acid

Acide folinique

Calcium citrovorum factor

Calcium folinate

Citrovorum factor

Folinate

Folinic acid

Folinic acid calcium salt

Folinic acid calcium salt USP27

Folinic acid-SF

L(-)-5-Formyl-5,6,7,8-tetrahydrofolic acid

L-Leucovorin

L-N-[p-[[(2-Amino-5-formyl-5,6,7,8-tetrahydro-4-hydroxy-6-pteridinyl)methyl]amino]benzoyl]-Glutamic acid

L-leucovorin

Leucal

Leucovorin calcium

Leucovorin folinic acid

Leucovorinum

Leukovorin

Levoleucovorin

N-(5-formyl-5,6,7,8-tetrahydropteroyl)-L-glutamic acid

N5-Formyl-5,6,7,8-tetrahydrofolate

N5-Formyl-5,6,7,8-tetrahydrofolic acid

N5-Formyltetrahydrofolate

N5-Formyltetrahydrofolic acid

Welcovorin

Wellcovorin

folinate

Everolimus

approved

Phase 3, Phase 1, Phase 2

1896

159351-69-6

6442177

Synonyms:

(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone

(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone

(1R,9S,12S,15R,16E,23S,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriacont

(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone

(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone

(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34as)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethy

07741_FLUKA

159351-69-6

40-O-(2-hydroxyethyl)-rapamycin

42-O-(2-Hydroxyethyl)rapamycin

Afinitor

CERTICAN(R)

CHEMBL1201755

Certican

D02714

DB01590

Everolimus

Everolimus (JAN/USAN/INN)

Everolimus [USAN]

LS-143292

MolPort-003-847-342

MolPort-003-925-588

NCGC00167512-01

NVP-RAD-001

RAD 001

RAD-001

RAD-001C

RAD001

RAD001, SDZ-RAD, Certican, Zortress, Afinitor, Everolimus

S1120_Selleck

SDZ-RAD

UNII-9HW64Q8G6G

Zortress

everolimus

Fluorouracil

approved

Phase 3, Phase 2, Phase 1

1791

51-21-8

3385

Synonyms:

1-fluoro-1h-pyrimidine-2,4-dione

1004-03-1

1upf

2,4-Dihydroxy-5-fluoropyrimidine

2,4-Dioxo-5-fluoropryimidine

2,4-Dioxo-5-fluoropyrimidine

47576_FLUKA

4921-97-5

5 FU Lederle

5 FU medac

5 Fluorouracil

5 Fluorouracil biosyn

5 HU Hexal

5-FU

5-FU (TN)

5-FU Lederle

5-FU medac

5-Faracil

5-Fluor-2,4(1H,3H)-pyrimidindion

5-Fluor-2,4(1H,3H)-pyrimidindion [Czech]

5-Fluor-2,4-dihydroxypyrimidin

5-Fluor-2,4-dihydroxypyrimidin [Czech]

5-Fluor-2,4-pyrimidindiol

5-Fluor-2,4-pyrimidindiol [Czech]

5-Fluoracil

5-Fluoracil [German]

5-Fluoracyl

5-Fluoro-2,4(1H,3H)-pyrimidinedione

5-Fluoro-2,4-pyrimidinedione

5-Fluoropyrimidin-2,4-diol

5-Fluoropyrimidine-2,4-dione

5-Fluorouracil

5-Fluorouracil-biosyn

5-Fluoruracil

5-Fluoruracil [German]

5-Fluracil

5-Ftouracyl

5-HU Hexal

5-fluoro uracil

5-fluoro-1H-pyrimidine-2,4-dione

5-fluoropyrimidine-2,4(1H,3H)-dione

5-fluorouracil

51-21-8

5FU

79108-01-3

AC-11201

AC1L1FTE

AC1Q4N2X

AI3-25297

AKOS000119162

AKOS003237897

AccuSite

Actino-Hermal

Adrucil

Adrucil (TN)

Allergan Brand of Fluorouracil

Arumel

BB_NC-0576

BSPBio_002048

C07649

C4H3FN2O2

CCRIS 2582

CHEBI:46345

CHEMBL185

CID3385

CPD0-1327

CPD000038082

CSP Brand of Fluorouracil

Carac

Carac (TN)

Carzonal

Cinco FU

Cytosafe

D005472

D00584

DB00544

Dakota Brand of Fluorouracil

Dakota, Fluorouracile

Dermatech Brand of Fluorouracil

Dermik Brand of Fluorouracil

DivK1c_000054

EINECS 200-085-6

EU-0100536

Effluderm

Effluderm (free base)

Efudex

Efudix

Efurix

F 6627

F0151

F6627_SIGMA

F8423_SIGMA

FT-0082524

Ferrer Brand of Fluorouracil

Fiverocil

Fluoro Uracil

Fluoro Uracile ICN

Fluoro-Uracile ICN

Fluoro-uracile

Fluoro-uracilo

Fluoroblastin

Fluoroplex

Fluoroplex (TN)

Fluorouracil

Fluorouracil (JP15/USP/INN)

Fluorouracil GRY

Fluorouracil Mononitrate

Fluorouracil Monopotassium Salt

Fluorouracil Monosodium Salt

Fluorouracil Potassium Salt

Fluorouracil Teva Brand

Fluorouracil [USAN:INN:BAN:JAN]

Fluorouracil-GRY

Fluorouracile

Fluorouracile Dakota

Fluorouracile [DCIT]

Fluorouracilo

Fluorouracilo Ferrer Far

Fluorouracilo [INN-Spanish]

Fluorouracilum

Fluorouracilum [INN-Latin]

Fluoruracil

Fluouracil

Flurablastin

Fluracedyl

Fluracil

Fluracilum

Fluri

Fluril

Fluro Uracil

Fluroblastin

Flurodex

Flurouracil

Flurox

Ftoruracil

Gry Brand of Fluorouracil

HMS1920O18

HMS2090I04

HMS2091F19

HMS500C16

HSDB 3228

Haemato Brand of Fluorouracil

Haemato fu

Haemato-fu

Hexal Brand of Fluorouracil

I07-0022

ICN Brand of Fluorouracil

IDI1_000054

IN1335

KBio1_000054

KBio2_001321

KBio2_003889

KBio2_006457

KBio3_001268

KBioGR_001253

KBioSS_001321

Kecimeton

LS-153

Lopac-F-6627

Lopac0_000536

MLS000069498

MLS002415705

MolPort-000-156-102

MolPort-003-990-447

MolPort-004-758-143

MolPort-004-758-144

MolPort-005-861-486

NCGC00015442-01

NCGC00015442-03

NCGC00015442-10

NCGC00091349-01

NCGC00091349-02

NCGC00091349-03

NCGC00091349-04

NCGC00091349-05

NCGC00091349-07

NCGC00091349-08

NCI60_001652

NINDS_000054

NSC 19893

NSC-19893

NSC19893

Neocorp Brand of Fluorouracil

Neofluor

Onkofluor

Onkoworks Brand of Fluorouracil

Phthoruracil

Phtoruracil

Queroplex

Ribofluor

Riemser Brand of Fluorouracil

Ro 2-9757

Ro-2-9757

Roche Brand of Fluorouracil

S1209_Selleck

SAM002264615

SMR000038082

SPBio_000291

SPECTRUM1500305

STK297802

Spectrum2_000076

Spectrum3_000434

Spectrum4_000557

Spectrum5_000718

Spectrum_000841

T5233394

TL8006093

Teva Brand of Fluorouracil

Timazin

U 8953

U-8953

UNII-U3P01618RT

UPCMLD-DP130

UPCMLD-DP130:001

URF

Ulup

WLN: T6MVMVJ EF

ZINC00897110

biosyn Brand of Fluorouracil

fluorouracil

inhibits thymilidate synthetase

medac Brand of Fluorouracil

nchembio.90-comp3

nchembio809-comp6

ribosepharm Brand of Fluorouracil

tetratogen

Oxaliplatin

approved, investigational

Phase 3, Phase 2, Phase 1

1412

61825-94-3

5310940, 9887054, 43805, 6857599, 9887054

Synonyms:

CHEMBL1201055

CID9887054

D01790

DACPLAT

Diaminocyclohexane Oxalatoplatinum

Eloxatin

Eloxatin (TN)

Elplat

Foloxatine

L-OHP

Oxalatoplatin

Oxalatoplatinum

Oxaliplatin (JAN/USAN/INN)

Oxaliplatin [Usan:Inn:Ban]

Oxaliplatino [Spanish]

Oxaliplatinum [Latin]

Oxaloplatine [French]

Oxaloplatino [Spanish]

Transplatin

oxaliplatin

oxaliplatine

oxaliplatino

oxaliplatinum

Sirolimus

approved, investigational

Phase 3, Phase 1, Phase 2

1896

53123-88-9

5284616, 6436030, 46835353

Synonyms:

(-)-Rapamycin

(-)-rapamycin

1fkb

1pbk

23,27-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine

23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine

23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29

3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone

53123-88-9

A422989, NSC226080

AC-722

AC1L1JH9

AC1L7MJ9

AC1L9ZMV

AY 22989

AY-22989

AY22989

Ambotz53123-88-9

Antibiotic AY 22989

BIDD:PXR0165

Bio1_000293

Bio1_000782

Bio1_001271

Bio2_000375

Bio2_000855

BiomolKI2_000084

C07909

C51H79NO13

CBiol_002007

CCRIS 9024

CHEBI:100923

CHEBI:9168

CHEMBL413

CID10213190

CID10795871

CID11949238

CID11959112

CID313006

CID478951

CID5040

CID5284616

CID5358081

CID5374464

CID5460439

CID5497196

CID5924240

CID6436030

CID6610270

CID6610346

CID6711160

CID6713081

CID9833581

CID9854379

CID9854380

CID9962926

CID9962928

D00753

DB00877

DE-109

DivK1c_006936

FT-0082351

HMS2089A21

HSDB 7284

KBio1_001880

KBio2_000410

KBio2_002978

KBio2_005546

KBio3_000779

KBio3_000780

KBioGR_000410

KBioSS_000410

LCP-Siro

LMPK06000003

LS-143290

MLS000028373

MS-R001

MolMap_000043

MolPort-003-959-433

NCGC00021305-05

NCI60_001851

NCIMech_000355

NSC 226080

NSC226080

Perceiva

QTL1_000069

R0395_SIAL

R0395_SIGMA

RAP

RAPA

RPM

Rapammune

Rapamune

Rapamune (TN)

Rapamycin

Rapamycin (TN)

Rapamycin C-7, analog 4

Rapamycin Immunosuppressant Drug

Rapamycin from Streptomyces hygroscopicus

S1039_Selleck

SIIA 9268A

SILA 9268A

SILA9268A

SMP1_000255

SMR000058564

Sirolimus

Sirolimus (RAPAMUNE)

Sirolimus (USAN/INN)

Sirolimus [USAN:BAN:INN]

Sirolimus, Rapamune,Rapamycin

SpecPlus_000840

UNII-W36ZG6FT64

UNM-0000358684

WY-090217

Wy 090217

heptadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy

nchembio.100-comp4

nchembio.2007.42-comp2

nchembio.79-comp1

nchembio762-comp1

nchembio883-comp3

rapamycin

sirolimus

Trastuzumab

approved, investigational

Phase 2, Phase 3, Phase 1

766

180288-69-1

9903

Synonyms:

180288-69-1

Anti HER2

Anti-erbB2 Monoclonal Antibody

D03257

HER2 Monoclonal Antibody

Herceptin

Herceptin (TN)

Ig gamma-1 chain C region

Trastuzumab

Trastuzumab (INN)

Trastuzumab (genetical recombination)

Trastuzumab (genetical recombination) (JAN)

trastuzumab

Tamoxifen

approved

Phase 3, Phase 2

380

10540-29-1

2733526

Synonyms:

(Z)-1-(p-Dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene

(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine

(Z)-2-(4-(1,2-diphenylbut-1-enyl)phenoxy)-N,N-dimethylethanamine

(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine

(Z)-2-(para-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine (IUPAC)

(Z)-2-[4-(1,2)-DIPHENYL-1-BUTENYL)-PHENOXY]-N,N-DIMETHYLETHANAMINE

(Z)-2-[p-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine

,citrate

1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene

1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene

1-p-.beta.-Dimethylamino-ethoxyphenyl-trans-1,2-diphenylbut-1-ene

1-p-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene

1-para-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene

10540-29-1

1ya4

2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine

2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine

54965-24-1 (citrate)

AC1MBZ3R

Apo-Tamox

Apo-tamox

BIDD:ER0008

BIDD:GT0009

BIDD:PXR0003

BPBio1_000278

BRD-K93754473-001-02-9

BRD-K93754473-048-05-3

BSPBio_000252

BSPBio_001150

BSPBio_001982

C07108

C26H29NO

CCRIS 3275

CHEBI:41774

CHEMBL83

CID2733526

Citofen

Crisafeno

D08559

DB00675

Diemon

EINECS 234-118-0

Gen-Tamoxifen

Gen-tamoxifen

HMS1362J11

HMS1792J11

HMS1990J11

HMS2090N08

HSDB 6782

ICI 47699

ICI-46,474

ICI-47699

IDI1_000258

IDI1_002170

Istubol

Kessar

L024126

LS-393

Lopac0_001203

MLS001332535

MLS001332536

MolPort-003-850-384

NCGC00024928-01

NCGC00024928-03

NCGC00024928-04

NCGC00024928-05

NCGC00024928-07

NCGC00024928-08

NCGC00024928-09

NCGC00024928-12

NSC727681

Noltam

Nolvadex

Nolvadex-D

Nourytam

Novaldex

Novo-Tamoxifen

Oncomox

PMS-Tamoxifen

Pms-Tamoxifen

Prestwick2_000146

Prestwick3_000146

QTL1_000079

Retaxim

SMR000059172

ST50511785

Spectrum5_001417

Spectrum5_002043

T5648_SIGMA

TAMOXIFEN (TAMOXIFEN CITRATE (54965-24-1))

TRANS FORM OF TAMOXIFEN

Tamizam

Tamofen

Tamone

Tamoplex (TN)

Tamoxasta

Tamoxen

Tamoxifen

Tamoxifen (INN)

Tamoxifen (TN)

Tamoxifen (Z)

Tamoxifen Citrate

Tamoxifen [INN:BAN]

Tamoxifen and its salts

Tamoxifene

Tamoxifene [INN-French]

Tamoxifeno

Tamoxifeno [INN-Spanish]

Tamoxifenum

Tamoxifenum [INN-Latin]

Tamoxifène

Tocris-0999

Tomaxithen

Trans-Tamoxifen

UNII-094ZI81Y45

UPCMLD-DP027

Valodex

Zemide

cMAP_000044

nchembio.140-comp7

nchembio.76-comp1

nchembio732-comp3

tamoxifen

trans-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine

trans-Tamoxifen

Irinotecan

approved, investigational

Phase 3, Phase 1, Phase 2

1080

97682-44-5, 100286-90-6

60838

Synonyms:

(+)-Irinotecan

(4S)-4,11-DIETHYL-4-HYDROXY-3,14-DIOXO-3,4,12,14-TETRAHYDRO-1H-PYRANO[3',4':6,7]INDOLIZINO[1,2-B]QUINOLIN-9-YL 1,4'-BIPIPERIDINE-1'-CARBOXYLATE

(4S)-4,11-Diethyl-4-hydroxy-3,14-dioxo-4,12-dihydro-1H-pyrano[3,4-f]quinolino[2,3-a]indolizin-9-yl 4-piperidylpiperidinecarboxylate

1u65

97682-44-5

AC-7469

AC1L1U0Z

AC1Q6PGI

BRD-K08547377-003-02-4

BSPBio_002346

Bio-0054

Biotecan

Biotecan (TN)

C16641

C33H38N4O6

CHEBI:105985

CHEMBL481

CID60838

CP0

Campothecin-11

Campto

Camptosar

Camptosar, Campto, CPT-11, Irinotecan

Camptothecin-11

D08086

DB00762

FT-0083650

HSDB 7607

IRINOTECAN HYDROCHLORIDE Trihydrate

IRINOTECAN, CPT-11

Irinotecan (INN)

Irinotecan Hcl

Irinotecan Hydrochloride

Irinotecan Hydrochloride Trihydrate

Irinotecan [INN:BAN]

Irinotecan hydrochloride

Irinotecanum

Irinotecanum [INN-Latin]

LS-44589

NCI60_005051

NSC728073

S1198_Selleck

TL8006026

UNII-7673326042

irinotecan

Lenograstim

approved

Phase 3, Phase 2, Phase 1

1202

135968-09-1

Synonyms:

G-CSF (CHO cell derived)

Glycosylated recombinant G-CSF

Glycosylated recombinant granulocyte colony stimulating factor

Granulocyte colony stimulating factor 3 (CHO cell derived)

Granulocyte colony-stimulating factor lenograstim

Lenograstim (genetical recombination)

Lenograstim rDNA

Carboplatin

approved

Phase 2, Phase 3, Phase 1

1980

41575-94-4

10339178, 498142, 38904

Synonyms:

(SP-4-2)-diammine[cyclobutane-1,1-dicarboxylato(2-)-kappa(2)O,O']platinum

/h1-3H2,(H,7,8)(H,9,10)

1,1-Cyclobutanedicarboxylate diammine platinum (II)

1,1-Cyclobutanedicarboxylate diammine platinum(II)

2*-1

2*1H2

41575-94-4

70903-55-8

AC-1457

AC1L8I6U

Ambap41575-94-4

BSPBio_003145

C 2538

C2043

C2538_SIGMA

C6H10N2O4Pt

CBDCA

CCRIS 3404

CHEBI:31355

CHEMBL1351

CHEMBL288376

CID10339178

CID2567

CID38904

CID426756

CID498142

CID5352133

CID6398587

CID6603770

Carbopaltin

Carboplatin

Carboplatin (JAN/USP/INN)

Carboplatin (USAN)

Carboplatin [USAN:INN:BAN:JAN]

Carboplatine

Carboplatine [French]

Carboplatino

Carboplatino [Spanish]

Carboplatinum

Carboplatinum [Latin]

Cbdca

Cyclobutane-1,1-dicarboxylate

D01363

DB00958

Diammine(1,1-cyclobutanedicarboxylato)platinum (II)

Diammine(cyclobutane-1,1-dicarboxylato(2-)-O,O')platinum

Diammine-1,1-cyclobutane dicarboxylate platinum II

DivK1c_000892

EINECS 255-446-0

EU-0100230

Ercar

HMS1921J16

HMS2090M05

HMS2092B22

HMS502M14

HSDB 6957

I14-2390

IDI1_000892

IUPAC: Azane

InChI=1/C6H8O4.2H2N.Pt/c7-4(8)6(5(9)10)2-1-3-6

JM 8

JM-8

KBio1_000892

KBio2_002009

KBio2_004577

KBio2_007145

KBio3_002645

KBioGR_000713

KBioSS_002009

LS-117689

Lopac-C-2538

Lopac0_000230

MolPort-003-665-501

MolPort-003-845-609

NCGC00015223-01

NCGC00093695-01

NCGC00094961-01

NCGC00094961-02

NCGC00094961-03

NCGC00162099-01

NCGC00162099-02

NCGC00167800-01

NCGC00178242-01

NINDS_000892

NSC 201345

NSC 241240

NSC-241240

NSC201345

NSC241240

Paraplatin

Paraplatin (TN)

Paraplatin, Carboplatin

Paraplatin-AQ

Platinum(+2) Cation

Platinum(II), (1, 1-cyclobutanedicar

Platinum, diammine(1,1-cyclobutanedicarboxylato(2-)-O,O')-, (SP-4-2)

Platinum, {diammine[1,1-cyclobut

S1215_Selleck

SPBio_000716

SPECTRUM1502106

Spectrum2_000898

Spectrum3_001503

Spectrum4_000337

Spectrum5_001094

Spectrum_001529

UNII-BG3F62OND5

azanide

carboplatin

cis -Diammine[1,1-cyclobutane-dicarboxylato] platinum

cis-(1,1-Cyclobutanedicarboxylato)diammineplatinum(II)

cis-(1,1-Cyclobutanedicarboxylato)diammineplatinum(ii)

cis-Diamine(1,1-cyclobutanedicarboxylato)platinum(II)

cis-Diamine[1,1-cyclobutanedicarboxylato]platinum(II)

cis-Diammine(1,1-cyclobutanedicarboxylato) platinum

cis-Diammine(1,1-cyclobutanedicarboxylato)platinum

cis-Diammine(1,1-cyclobutanedicarboxylato)platinum(II)

cis-Diammine(cyclobutanedicarboxylato)platinum II

cyclobutane-1,1-dicarboxylic acid

diammine[cyclobutane-1,1-dicarboxylato(2-)-k2O1,O1]platinum

nchembio.573-comp10

nchembio773-comp2

nchembio873-comp3

platinum(2+)

Cyclophosphamide

approved, investigational

Phase 3, Phase 2, Phase 1

2829

50-18-0, 6055-19-2

2907

Synonyms:

(+-)-Cyclophosphamide

(-)-Cyclophosphamide

(RS)-Cyclophosphamide

1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine

1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin

2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide

4-Hydroxy-cyclophosphan-mamophosphatide

50-18-0

60007-95-6

6055-19-2 (monohydrate)

75526-90-8

AC1L1EQQ

AI3-26198

ASTA

ASTA B518

Anhydrous cyclophosphamide

Asta B 518

B 518

B-518

BRN 0011744

BSPBio_002099

Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester

C 0768

C07888

C7H15Cl2N2O2P

CB 4564

CB-4564

CCRIS 188

CHEBI:4027

CHEMBL32520

CHEMBL88

CID2907

CPA

CTX

Ciclofosfamida

Ciclofosfamida [INN-Spanish]

Ciclofosfamide

Ciclophosphamide

Ciclophosphamide [INN]

Clafen

Claphene

Cycloblastin

Cyclophosphamid

Cyclophosphamide

Cyclophosphamide (INN)

Cyclophosphamide (TN)

Cyclophosphamide (anhydrous form)

Cyclophosphamide (anhydrous)

Cyclophosphamide Monohydrate

Cyclophosphamide Sterile

Cyclophosphamide anhydrous

Cyclophosphamide, (+-)-Isomer

Cyclophosphamides

Cyclophosphamidum

Cyclophosphamidum [INN-Latin]

Cyclophosphan

Cyclophosphane

Cyclophosphanum

Cyclophosphoramide

Cyclostin

Cyklofosfamid

Cyklofosfamid [Czech]

Cytophosphan

Cytophosphane

Cytoxan

Cytoxan (TN)

Cytoxan Lyoph

D,L-Cyclophosphamide

D07760

DB00531

DivK1c_000246

EINECS 200-015-4

EU-0100238

Endoxan

Endoxan R

Endoxan-Asta

Endoxana

Endoxanal

Endoxane

Enduxan

Genoxal

HMS2090A12

HSDB 3047

Hexadrin

IDI1_000246

KBio1_000246

KBio2_001338

KBio2_003906

KBio2_006474

KBio3_001319

KBioGR_000888

KBioSS_001338

LS-1302

LS-99787

Ledoxina

Lopac-C-0768

Lopac0_000238

Lyophilized Cytoxan

Mitoxan

MolPort-001-783-420

N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide

N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide

NCGC00015209-01

NCGC00015209-03

NCGC00015209-06

NCGC00091741-02

NCGC00091741-03

NCI-C04900

NCI60_002097

NINDS_000246

NSC 26271

NSC-26271

NSC26271

NSC273033

NSC273034

Neosar

Occupation, cyclophosphamide exposure

Procytox

RCRA waste no. U058

Rcra Waste Number U058

Rcra waste number U058

Revimmune

S1217_Selleck

SK 20501

SPBio_001071

STK177249

STOCK2S-91217

Semdoxan

Sendoxan

Senduxan

Spectrum2_001146

Spectrum3_000370

Spectrum4_000304

Spectrum5_000795

Spectrum_000858

UNII-6UXW23996M

WLN: T6MPOTJ BO BN2G2G

Zyklophosphamid

Zyklophosphamid [German]

bis(2-Chloroethyl)phosphami de cyclic propanolamide

bis(2-Chloroethyl)phosphamide cyclic propanolamide ester

cyclophosphamide

Capecitabine

approved, investigational

Phase 3, Phase 2, Phase 1

1296

154361-50-9

60953

Synonyms:

(1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamic acid pentyl ester

154361-50-9

158798-73-3

5'-Deoxy-5-fluoro-N-((pentyloxy)carbonyl)cytidine

5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine

AC1L1U83

AC1Q4KU8

Ambap154361-50-9

C110904

C12650

C15H22FN3O6

CAPE

CAPECITABINE

CHEBI:31348

CHEMBL1773

CID60953

Capecitabin

Capecitabina

Capecitabine (JAN/USAN/INN)

Capecitabine [USAN]

Capecitabinum

Capecitibine

Capiibine

Carbamic acid, (1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-, pentyl ester

Caxeta

D01223

DB01101

FT-0082472

HSDB 7656

LS-59070

MolPort-005-938-254

N(4)-Pentyloxycarbonyl-5'-deoxy-5-fluorocytidine

Pentyl 1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate

Pentyl [1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamate

R-340

R340

RG-340

Ro 09-1978

Ro 09-1978/000

Ro-09-1978

Ro-09-1978/000

S1156_Selleck

UNII-6804DJ8Z9U

Xabine

Xeloda

Xeloda (TN)

Xeloda, Captabin, Capecitabine

ZINC03806413

capecitabina

capecitabine

capecitabinum

pentyl N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]carbamate

Paclitaxel

approved, vet_approved

Phase 3, Phase 2, Phase 1, Early Phase 1

2758

33069-62-4

36314

Synonyms:

(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester

12-benzoate, 9-ester with (2R,3S)-N-benzoyl-3-phenylisoserine

157069-30-2

33069-62-4

5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine

7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete, benzenepropanoic acid deriv.

7,11-Methano-5H-cyclodeca[3,4]benz[1,2-b]oxete,benzenepropanoic acid deriv.

7-Epi-Paclitaxel

7-Epi-Taxol

7-Epipaclitaxel

7-Epitaxol

7-epi-Paclitaxel

7-epi-Taxol

AB00513812

ABI 007

ABI-007

ABI007

AC-675

AC1L1IOG

AC1L1VJI

AC1L9AVF

ACon1_002231

ANX-513

Abraxane

Abraxane (TN)

Abraxane I.V. Suspension

Abraxis BioScience brand of albumin-bound paclitaxel

Ambotz33069-62-4

Anzatax

Asotax

BIDD:PXR0046

BMS 181339-01

BMS-181339

BMS-181339-01

BPBio1_000320

BRD-A23723433-001-01-2

BRD-A28746609-001-04-0

BRD-K62008436-001-03-1

BSPBio_000290

BSPBio_001152

BSPBio_002614

Bio-0076

Bio1_000362

Bio1_000851

Bio1_001340

Bio2_000416

Bio2_000896

Bristaxol

C07394

C466458

C47H51NO14

CCRIS 8143

CHEBI:103439

CHEBI:45863

CHEMBL100910

CHEMBL418410

CHEMBL48

CID36314

CID441276

CID4666

CID6713921

CID6915727

CPD-8718

Capxol

D00491

DB01229

DHP-107

DHP-208

DRG-0190

DTS-301

DivK1c_000441

EU-0101201

Ebetaxel

EmPAC

Epitaxol

Genaxol

Genetaxyl

Genexol

Genexol-PM

HMS1362J13

HMS1568O12

HMS1792J13

HMS1922K08

HMS1990J13

HMS2090D07

HMS2093K15

HMS501G03

HSDB 6839

I06-0014

IDI1_000441

IDI1_002171

Intaxel

KBio1_000441

KBio2_000492

KBio2_002016

KBio2_002509

KBio2_003060

KBio2_004584

KBio2_005077

KBio2_005628

KBio2_007152

KBio2_007645

KBio3_000903

KBio3_000904

KBio3_001834

KBio3_002987

KBioGR_000492

KBioGR_001893

KBioGR_002509

KBioSS_000492

KBioSS_002016

KBioSS_002517

LMPR0104390001

LS-31070

LipoPac

Lopac0_001201

MBT 0206

MEGxp0_001940

MLS000863266

MLS001077297

MLS002154218

MLS002172439

MLS002695976

MPI-5018

Micellar Paclitaxel

Mitotax

MolPort-001-742-627

MolPort-003-665-783

MolPort-003-932-365

NCGC00024995-02

NCGC00024995-03

NCGC00024995-04

NCGC00024995-05

NCGC00024995-06

NCGC00024995-07

NCGC00164367-01

NCGC00164367-02

NCGC00164367-03

NCI60_000601

NINDS_000441

NK 105

NP-010981

NSC 125973

NSC-125973

NSC125973

NSC358882

Nanotaxel

Neuro_000060

Nova-12005

OAS-PAC-100

OncoGel

Onxal

Onxol

Onxol, Taxol, Nov-Onxol, Paclitaxel

P1632

Paclical

Pacligel

Paclitaxel

Paclitaxel (JAN/USP)

Paclitaxel (JAN/USP/INN)

Paclitaxel (Taxol)

Paclitaxel [USAN:INN:BAN]

Paxceed

Paxene

Paxoral

Plaxicel

Praxel

Prestwick0_000155

Prestwick1_000155

Prestwick2_000155

Prestwick3_000155

Probes2_000350

QW 8184

S-8184 Paclitaxel Injectable Emulsion

S1150_Selleck

SDCCGMLS-0066823.P001

SDP-013

SMP1_000228

SMR000394086

SMR000857385

SPBio_000943

SPBio_002229

SPECTRUM1503908

ST50306996

Spectrum2_000872

Spectrum3_001057

Spectrum4_001197

Spectrum5_001491

Spectrum_001536

T 7402

T1912_SIGMA

T7191_SIGMA

T7402_SIGMA

TA1

TAXOL (TN)

TAXOL, 10-EPI,

TXL

TaxAlbin

Taxol

Taxol A

Taxol Konzentrat

Taxol.RTM. (Registered Trademark)

UNII-P88XT4IS4D

UPCMLD-DP108:001

UPCMLD-DP108:002

Vascular Wrap

Xorane

Yewtaxan

abi-007

albumin-bound paclitaxel

cMAP_000068

nab-paclitaxel

nchembio.188-comp1

nchembio.2007.34-comp9

nchembio.215-comp9

nchembio853-comp6

paclitaxel

weekly paclitaxel

Pancrelipase

approved

Phase 3, Phase 2, Phase 1

935

53608-75-6

Synonyms:

1,4-alpha-D- glucan glucanohydrolase

Pancreatic alpha-amylase precursor

Pancrelipase (amylase

lipase

protease)

Bevacizumab

approved, investigational

Phase 3, Phase 2, Phase 1

1968

216974-75-3

Synonyms:

216974-75-3

Avastin

Avastin (TN)

Bevacizumab

Bevacizumab (genetical recombination)

Bevacizumab (genetical recombination) (JAN)

D06409

R-435

anti-VEGF monoclonal antibody

antiVEGF

bevacizumab

Miconazole

approved, investigational, vet_approved

Phase 3, Phase 1, Phase 2

3624

22916-47-8

4189

Synonyms:

(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole

1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole

1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole

1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole

1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole

1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole

1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole

1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole

1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole

1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole

22832-87-7 (NITRATE)

22916-47-8

75319-47-0

AB00053500

AC1L1HM1

AKOS001574474

Aflorix(nitrate)

Albistat(nitrate)

Andergin(nitrate)

BPBio1_000279

BRD-A82396632-001-03-0

BRD-A82396632-008-02-7

BRN 0965511

BSPBio_000253

BSPBio_002033

CCRIS 7924

CHEBI:6923

CHEMBL91

CID4189

CPD-4501

Conofite(nitrate)

D00416

DB01110

Dactarin

Daktarin IV

Daktarin iv

DivK1c_000156

EINECS 245-324-5

Epi-Monistat(nitrate)

Femizol-M

Florid(nitrate)

Gyno-Daktar(nitrate)

HMS1568M15

HMS2090B21

I14-14342

IDI1_000156

Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)

KBio1_000156

KBio2_001445

KBio2_004013

KBio2_006581

KBio3_001533

KBioGR_000581

KBioSS_001445

LS-78378

Lotrimin AF(nitrate)

MCZ

MJR 1762

MLS002222203

Micantin (nitrate)

Miconasil Nitrate

Miconazol

Miconazol [INN-Spanish]

Miconazole

Miconazole (JP15/USP/INN)

Miconazole 3

Miconazole 3 Combination Pack

Miconazole 7 Combination Pack

Miconazole [USAN:BAN:INN:JAN]

Miconazole nitrate salt

Miconazole-7

Miconazolo

Miconazolo [DCIT]

Miconazolum

Miconazolum [INN-Latin]

Micozole

Minostate

MolPort-002-557-553

Monazole 7

Monista (nitrate)

Monistat

Monistat (TN)

Monistat 1 Combination Pack

Monistat 3 Dual-Pak

Monistat 3 Vaginal Ovules

Monistat 5 Tampon

Monistat 7 Dual-Pak

Monistat 7 Vaginal Suppositories

Monistat Dual- PAK

Monistat IV

Monistat iv (TN)

Monistat iv (tn)

Monistat-Derm

NCI60_001353

NCI60_001380

NINDS_000156

NSC 170986

NSC169434

NSC170986

Novo-Miconazole Vaginal Ovules

Oprea1_091955

Prestwick0_000067

Prestwick1_000067

Prestwick2_000067

Prestwick3_000067

Prestwick_335

R 18134

R-14,889

SMR001307249

SPBio_000976

SPBio_002174

STK834405

STOCK1S-93556

Spectrum2_001048

Spectrum3_000507

Spectrum4_000061

Spectrum5_001297

Spectrum_000965

UNII-7NNO0D7S5M

Vusion

Zimycan

imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)

miconazole

Vinblastine

approved

Phase 3, Phase 2, Phase 1

413

865-21-4

13342, 241903

Synonyms:

(2ALPHA,2'BETA,3BETA,4ALPHA,5BETA)-VINCALEUKOBLASTINE

(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine

(2xi,3beta,4'beta,19xi)-vincaleukoblastine

(3aR-(3aalpha,4beta,5beta,5abeta,9(3R*,5S*,7R*,9S*),10bR*,13aalpha))-methyl 4-(acetyloxy)-3a-ethyl-9-(5-ethyl-1,4,5,6,7,8,9,10-octahydro-5-hydroxy-9-(methoxycarbonyl)-2H-3,7-methanoazacycloundecino(5,4-b)indol-9-yl)-3a,4,5,5a,6,11,12,13a-octahydro-5-hydroxy-8-methoxy-6-methyl-1H-indolizino(8,1-cd)carbazole-5-carboxylate

143-67-9

1z2b

29060-LE

865-21-4

AC-20335

AC1L21JC

AC1L68D2

AC1MXZJ2

BIDD:PXR0201

BRD-K01188359-065-02-5

BSPBio_001228

BSPBio_003594

Bio-0111

C07201

C46H58N4O9

CCRIS 9002

CHEBI:171516

CHEBI:27375

CHEMBL159

CHEMBL607706

CID13342

CID241903

CID3823887

CID6710780

D08675

DB00570

EINECS 212-734-0

HMS2090K05

HSDB 3263

KBio3_003033

LS-1859

LS-187263

MolPort-002-518-262

MolPort-005-910-359

NCGC00022585-04

NCGC00181127-01

NCI-C04842

NCI60_004200

NChemBio.2007.10-comp22

NDC 0002-1452-01

NSC 47842

Neuro_000020

Nincaluicolflastine

Rozevin

SPBio_000680

STOCK1N-38480

Spectrum2_000890

Spectrum3_001994

UNII-5V9KLZ54CY

VLB

VR-8

Velban

Velbe

Vinblastin

Vinblastina

Vinblastina (TN)

Vinblastina [DCIT]

Vinblastina [Dcit]

Vinblastine

Vinblastine (INN)

Vinblastine Sulfate

Vinblastine [INN:BAN]

Vinblastinum

Vinblastinum [INN-Latin]

Vincaleucoblastin

Vincaleucoblastine

Vincaleukoblastine

Vincoblastine

nchembio873-comp22

vinblastine

Sunitinib

approved, investigational

Phase 3, Phase 2

500

341031-54-7, 557795-19-4

5329102

Synonyms:

(2S)-2-hydroxybutanedioic acid

1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-, (2S)-hydroxybutanedioate (1:1)

326914-13-0

341031-54-7

5-(5-FLUORO-2-OXO-1,2-DIHYDRO-INDOL-3-YLIDENEMETHYL)-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID (2-DIETHYLAMINO-ETHYL)-AMIDE

557795-19-4

AC1NS62J

AC1O5CMQ

AKOS005145765

Butanedioic acid, hydroxy-, (2S)-, compd. with N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (1:1)

CHEBI:38940

CHEBI:550864

CHEMBL1567

CHEMBL535

CID5329102

CID6456015

D06402

D08552

DB01268

DB07417

EN002687

FT-0083555

FT-0083556

I01-1229

K00588a

KS-5022

LS-186078

LS-187023

LS-187648

MolPort-003-986-763

N-(2-(Diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (2S)-hydroxybutanedioate

N-(2-diethylaminoethyl)-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide

N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide

NCGC00164631-01

NSC736511

NSC750690

PDGF TK antagonist

PHA-290940AD

PNU-290940AD

S1042_Selleck

ST51053712

SU 011248

SU 11248

SU-010398

SU-011248 L-malate salt

SU-11248

SU-11248 L-malate salt

SU-11248J

SU-12662

SU010398

SU011248

SU011248 L-malate salt

SU11248

Su-011248

Sunitanib

Sunitinib

Sunitinib (INN)

Sunitinib (free base)

Sunitinib malate

Sunitinib malate (JAN/USAN)

Sunitinib malate [USAN]

Sunitinibum

Sutent

Sutent (TN)

Sutent, SU-11248

TL8002546

UNII-LVX8N1UT73

UNII-V99T50803M

sunitinib

sunitinibum

Estradiol

approved, investigational, vet_approved

Phase 3, Phase 2, Phase 1

1283

50-28-2

5757, 53477783

Synonyms:

(+)-3,17b-Estradiol

(17b)-Estra-1,3,5(10)-triene-3,17-diol

(17beta)-Estra-1,3,5(10)-triene-3,17-diol

.alpha.-Estradiol

.alpha.-Oestradiol

.beta.-Estradiol

.beta.-Oestradiol

1,3,5[10]-Estratriene-3,17beta-diol 3-sulfate

1,3,5[10]-Estratriene-3,17beta-diol 3-sulphate

13b-Methyl-1,3,5(10)-gonatriene-3,17b-ol

17 beta-Estradiol

17-.BETA.-Estradiol

17-E

17-beta

17-beta-OH-estradiol

17-beta-estradiol

17.beta.-Estradiol

17.beta.-Oestradiol

17E

17b-Estradiol

17b-Oestradiol

17beta Oestradiol

17beta oestradiol

17beta-Estra-1,3,5(10)-triene-3,17-diol

17beta-Estradiol

17beta-Oestradiol

1jgl

1qkt

1qku

2d06

3,17-Epidihydroxyestratriene

3,17-beta-Estradiol

3,17-beta-Oestradiol

3,17.beta.-Estradiol

3,17b-Dihydroxyestra-1,3,5(10)-triene

3,17b-Estradiol

3,17beta-Estradiol

3,17beta-dihydroxy-1,3,5[10]-estratriene 3-sulfate

3,17beta-dihydroxy-1,3,5[10]-estratriene 3-sulphate

50-28-2

73459-61-7

873662-39-6

AC-10460

AC1L1L2K

Aerodiol

Agofollin

Alora

Altrad

Amnestrogen

Aquadiol

B-Estradiol

BEDOs

BIDD:ER0125

BIDD:PXR0065

BPBio1_000532

BSPBio_000482

BSPBio_001065

Bardiol

Benzhormovarine

Beta-estradiol

Bio-0812

Bio-E-Gel

Bio1_000403

Bio1_000892

Bio1_001381

Bio2_000363

Bio2_000843

C00951

C18H24O2

CCRIS 280

CHEBI:16469

CHEMBL135

CID5757

CMC_11154

CPD-352

CPD000059126

Climaderm

Climara

Climara (TN)

Climara Forte

Compudose

Compudose 200

Compudose 365

Corpagen

D-3,17beta-Estradiol

D-Estradiol

D-Oestradiol

D00105

DB00783

Dermestril

Destradiol

Dihydro-Theelin

Dihydrofollicular hormone

Dihydrofolliculin

Dihydromenformon

Dihydrotheelin

Dihydroxyesterin

Dihydroxyestrin

Dihydroxyoestrin

Dimenformon

Diogyn

Diogynets

Divigel

Divigel (TN)

E 2

E 8875

E(sub 2)

E0025

E1024_SIGMA

E1132_SIGMA

E2257_SIGMA

E2758_SIGMA

E8875_SIGMA

EINECS 200-023-8

EU-0100503

Elestrin

Encore

Epiestriol 50

Esclim

Estra-1,3,5(10)-triene-3,17b-diol

Estrace

Estrace (TN)

Estraderm

Estraderm (TN)

Estraderm MX

Estraderm TTS

Estraderm TTS 100

Estraderm TTS 50

Estradiol

Estradiol [USAN:INN]

Estradiol-17 beta

Estradiol-17-beta

Estradiol-17.beta.

Estradiol-17beta

Estradiol-3,17beta

Estradiolo

Estradiolo [DCIT]

Estradiolum

Estradiolum [INN]

Estradot

Estraldine

Estrapak 50

Estrasorb

Estrasorb (TN)

Estreva

Estrifam

Estring

Estring (TN)

Estring Vaginal Ring

Estring vaginal ring

Estroclim

Estroclim 50

Estrodiolum

Estrofem 2

Estrofem Forte

Estrogel

Estrogel (TN)

Estrogel HBF

Estrovite

Evamist

Evorel

Extrasorb

Femanest

Femestral

Femestrol

Femogen

Fempatch

Femtrace

Femtran

Follicyclin

Gelestra

Ginedisc

Ginosedol

GynPolar

Gynergon

Gynestrel

Gynodiol

Gynoestryl

HMS1362E07

HMS1569I04

HMS1792E07

HMS1990E07

HMS2051C17

HMS2090E18

HSDB 3589

IDI1_002118

Innofem

Innofem (TN)

KBio2_000405

KBio2_002269

KBio2_002973

KBio2_004837

KBio2_005541

KBio2_007405

KBio3_000769

KBio3_000770

KBio3_002749

KBioGR_000405

KBioGR_002269

KBioSS_000405

KBioSS_002270

LMST02010001

LS-137

Lamdiol

Lio-Oid

Lopac0_000503

MLS000069494

MLS000758312

MLS001076331

Macrodiol

Macrol

Menest

Menorest

Menostar

Microdiol

MolPort-001-794-632

NCGC00091544-00

NCGC00091544-01

NCGC00091544-02

NCGC00091544-04

NCGC00091544-05

NCGC00091544-06

NCGC00091544-07

NCGC00091544-08

NCGC00091544-09

NCGC00091544-12

NCGC00179321-01

NCGC00179321-02

NSC-9895

NSC9895

Nordicol

Oesclim

Oestergon

Oestra-1,3,5(10)-triene-3,17b-diol

Oestradiol

Oestradiol Berco

Oestradiol R

Oestradiol-17-beta

Oestradiol-17.beta.

Oestradiol-17beta

Oestradiolum

Oestrogel

Oestroglandol

Oestrogynal

Ovahormon

Ovasterol

Ovastevol

Ovociclina

Ovocyclin

Ovocycline

Ovocylin

Perlatanol

Polyestradiol

Prestwick0_000441

Prestwick1_000441

Prestwick2_000441

Prestwick3_000441

Prestwick_207

Primofol

Profoliol

Profoliol B

Progynon

Progynon DH

Progynon-DH

S-21400

S1709_Selleck

SAM001247032

SK-Estrogens

SL-1100

SMP1_000121

SMR000059126

SPBio_002421

Sandrena 1

Sandrena Gel

Sisare Gel

Spectrum5_002055

Syndiol

Systen

Tradelia

Trial SAT

Trocosone

UNII-4TI98Z838E

VIVELLE-DOT

Vagifem

Vagifem (TN)

Vivelle

Vivelle (TN)

Zerella

Zesteem

Zesteen

Zumenon

[2,4,6,7-3H]-E2

[3H]-estradiol

[3H]]estradiol

b-Estradiol

beta-Estradiol

beta-Estradiol 3-sulfate

beta-Estradiol 3-sulphate

bmse000642

cMAP_000005

cis-Estradiol

cis-Oestradiol

component of Menrium

delta-Estradiol

delta-Oestradiol

estradiol

estradiol-17beta

nchembio.168-comp3

nchembio.76-comp2

nchembio775-comp2

nchembio794-comp6

nchembio860-comp1

progynon

Vinorelbine

approved, investigational

Phase 3, Phase 2, Phase 1

371

71486-22-1

60780, 44424639

Synonyms:

5'-Noranhydrovinblastine

71486-22-1

AC1L1KVK

AC1L1TWQ

AC1L75Q4

ANX-530

Ambap71486-22-1

BIDD:PXR0186

C45H54N4O8

CHEBI:480999

CHEMBL607994

CID355119

CID5311497

CID5672

CID60780

CID6426842

D08680

DB00361

Eunades

Exelbine

HMS2090E13

HSDB 7665

I06-0084

I06-0085

KW 2307

KW 2307 base

KW-2307

LS-97533

MolPort-006-822-661

MolPort-006-823-869

NCGC00165966-02

NVB

Navelbine

Navelbine (TN)

Navelbine Base

Navelbine base

Nor-5'-anhydrovinblastine

SDP-012

UNII-Q6C979R91Y

Vinorelbin

Vinorelbina

Vinorelbina [Spanish]

Vinorelbine

Vinorelbine (INN)

Vinorelbine Bitartrate

Vinorelbine Ditartarate

Vinorelbine Ditartrate

Vinorelbine Tartrate

Vinorelbine [INN:BAN]

Vinorelbine ditartrate

Vinorelbine tartrate

Vinorelbinum

Vinorelbinum [Latin]

methyl (2b,3b,4b,5a,12b,19a)-4-(acetyloxy)-15-[(6R,8S)-4-ethyl-8-(methoxycarbonyl)-1,3,6,7,8,9-hexahydro-2,6-methanoazecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate

methyl (2beta,3beta,4beta,5alpha,12beta,19alpha)-4-acetoxy-15-[(6R,8S)-4-ethyl-8-(methoxycarbonyl)-1,3,6,7,8,9-hexahydro-2,6-methanoazecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate

vinorelbine

Epirubicin

approved

Phase 3, Phase 2, Phase 1

383

56420-45-2

41867

Synonyms:

(1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside

(1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside

(7S,9R)-7-[(2S,4S,5R,6S)-4-Amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione

(7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione

10-((3-amino-2,3,6-trideoxy-beta-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-(8S-cis)-5,12-naphthacenedione

4'-Epi-DXR

4'-Epiadriamycin

4'-Epidoxorubicin

4'-epi-DX

4'-epi-Doxorubicin

4'-epidoxorubicin

4-Epidoxorubicin

56390-09-1

56390-09-1 (hydrochloride)

56420-45-2

57918-25-9

AC1L26NP

AC1Q6JIV

BRN 1445813

C11230

C27H29NO11

CCRIS 2261

CHEBI:47898

CHEMBL417

CID41867

D07901

DB00445

Ellence

Epi-DX

Epi-Dx

Epiadriamycin

Epidoxorubicin

Epirubicin

Epirubicin (INN)

Epirubicin [INN:BAN]

Epirubicina

Epirubicina [INN-Spanish]

Epirubicina [Spanish]

Epirubicine

Epirubicine [French]

Epirubicine [INN-French]

Epirubicinum

Epirubicinum [INN-Latin]

Epirubicinum [Latin]

Farmorubicin (TN)

HSDB 6962

IMI 28

LS-187190

LS-93992

MLS000759412

NChemBio.2007.10-comp15

NSC 256942

NSC-256942

NSC256942

Pharmorubicin Pfs

Pidorubicin

Pidorubicina

Pidorubicina [INN-Spanish]

Pidorubicine

Pidorubicine [INN-French]

Pidorubicinum

Pidorubicinum [INN-Latin]

Ridorubicin

SMR000466308

Triferric doxorubicin

UNII-3Z8479ZZ5X

WP 697

Levoleucovorin

approved

Phase 3, Phase 1, Phase 2

711

68538-85-2

Synonyms:

(6S)-5-Formyl-5,6,7,8-tetrahydrofolic acid

(6S)-5-formyltetrahydrofolic acid

(6S)-Folinic acid

(6S)-Leucovorin

(S)-Leucovorin

Citrovorum factor

L-Folinic acid

Levofolene

Levofolinic acid

N-[4-({[(6S)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamic acid

Denosumab

approved

Phase 3, Phase 2

130

615258-40-7

Synonyms:

615258-40-7

AMG-162

D03684

Denosumab

Denosumab (USAN)

Denosumab (genetical recombination)

Denosumab (genetical recombination) (JAN)

Prolia

Xgeva

Sorafenib

approved, investigational

Phase 3, Phase 2, Phase 1

692

284461-73-0

216239, 406563

Synonyms:

284461-73-0

4(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide

4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide

4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic acid methyamide-4-methylbenzenesulfonate

4-(4-{3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide

4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide

4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide

4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide

4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide

4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE

AB1004622

AC-1674

AC1L50CF

BAX

BAY 43-9006

BAY 43-9006 (free base)

BAY 43-9006 tosylate salt

BAY 439006

BAY 54-9085 (tosylate salt)

BAY-43-0006

BAY-43-9006

BAY-54-9085

BAY43-9006

BRD-K23984367-001-01-8

Bio-0100

CHEBI:47228

CHEBI:50924

CHEMBL1336

CID216239

D08524

DB00398

DB07438

EN002709

I06-0856

K00597a

Kinome_766

LS-186067

LS-187021

LS-187788

MolPort-003-850-270

N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea

N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea

N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcar bamoyl)-4-pyridyloxy)phenyl)urea

N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea

NCGC00167488-01

NSC-724772

NSC747971

Nexavar

STK627350

Sorafenib

Sorafenib (INN)

Sorafenib [INN]

Sorafenib tosylate

Sorafenibum

UNII-9ZOQ3TZI87

ZINC01493878

nchembio.117-comp17

sorafenib

sorafenibum

Somatostatin

approved

Phase 2, Phase 3, Phase 1

229

38916-34-6, 51110-01-1

53481605

Synonyms:

growth hormone-inhibiting hormone (GHIH)

somatotropin release-inhibiting factor (SRIF)

somatotropin release-inhibiting hormone

Zoledronic acid

approved

Phase 2, Phase 3

290

118072-93-8

68740

Synonyms:

(1-Hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid

(1-hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid

(1-hydroxy-2-imidazol-1-yl-1-phosphonoethyl)phosphonic acid

(1-hydroxy-2-imidazol-1-yl-phosphonoethyl)phosphonic acid monohydrate

(1-hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid

118072-93-8

2-(imidazol-1-yl)-1-hydroxyethane-1,1-diphosphonic acid

2-(imidazol-1-yl)-1-hydroxyethylidene-1,1-bisphosphonic acid

AC-1092

AC1L2ACJ

AC1Q6RN3

AKOS005145739

Aclasta

Anhydrous Zoledronic Acid

BIDD:GT0292

BIDD:PXR0134

Bio-0112

Bisphosphonate 3

C088658

CGP 42'446

CGP 42446

CGP 42446A

CGP-42'446

CGP-42446

CHEBI:46557

CHEMBL924

CID68740

D08689

DB00399

FT-0082657

HMS2089O09

I06-0710

KS-1132

LS-181815

MolPort-002-885-874

MolPort-003-850-890

NCGC00159521-02

NCGC00159521-03

NSC721517

Novartis brand of zoledronic acid

Reclast

Reclast (TN)

S00092

S1314_Selleck

UNII-70HZ18PH24

ZOL

Zol

Zoledronate

Zoledronic Acid Anhydrous

Zoledronic Acid, Anhydrous

Zoledronic acid

Zoledronic acid (INN)

Zoledronic acid [USAN:INN]

Zometa

Zometa (Novartis)

Zometa (TN)

Zometa Concentrate

Zometa, Zomera, Aclasta and Reclast, Zoledronic Acid

[1-hydroxy-2-(1H-imidazol-1-yl)ethane-1,1-diyl]bis(phosphonic acid)

Gemcitabine

approved

Phase 3, Phase 2, Phase 1

1974

95058-81-4

60750

Synonyms:

103882-84-4

122111-03-9

2',2'-DiF-dC

2',2'-Difluoro-2'-deoxycytidine

2',2'-Difluorodeoxycytidine

2'-Deoxy-.beta.-D-2',2'-difluorocytidine

2'-Deoxy-2',2'-difluorocytidine

4-Amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one

4-Amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl) tetrahydrofuran-2-yl]-1H-pyrimidin-2-one

4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one

4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one

95058-81-4

AB1004842

AC1L1TUQ

C07650

CCRIS 8984

CHEBI:175901

CHEMBL888

CID60750

Cytidine, 2'-deoxy-2',2'-difluoro-2'-Deoxy-.beta.-D-2',2'-difluorocytidine

D02368

DB00441

DDFC

DFDC

DFdC

DFdCyd

Folfugem

GEO

Gamcitabine

GemLip

Gemcel

Gemcin

Gemcitabin

Gemcitabina

Gemcitabina [INN-Spanish]

Gemcitabine

Gemcitabine (USAN/INN)

Gemcitabine HCl

Gemcitabine hydrochloride

Gemcitabine stereoisomer

Gemcitabinum

Gemcitabinum [INN-Latin]

Gemtro

Gemzar

Gemzar (hydrochloride)

HMS2089P10

HSDB 7567

Inno-D07001

LS-59139

LY 188011

LY-188011

LY188011

NCGC00168784-01

NChemBio.2007.10-comp25

NSC 613327

NSC613327

TL8005979

UNII-B76N6SBZ8R

ZINC18279854

Zefei

gemcitabine

nchembio.573-comp7

nchembio.90-comp2

Cisplatin

approved

Phase 2, Phase 3, Phase 1

2690

15663-27-1

84093, 441203, 2767

Synonyms:

(SP-4-1)-diamminedichloridoplatinum

(SP-4-1)-diamminedichloroplatinum

(SP-4-2)-diamminedichloridoplatinum

(SP-4-2)-diamminedichloroplatinum

Abiplatin

Biocisplatinum

Briplatin

CACP

CDDP

CHEBI:35852

CID441203

CPD0-1392

CPDC

CPDD

Carboquone

Cis Pt II

Cis-DDP

Cis-Diaminedichloroplatinum

Cis-Diamminedichloroplatinum

Cismaplat

Cisplatine

Cisplatino

Cisplatinum

Cisplatyl

Citoplationo

DB00515

DDP

DDPT

Diamminedichloroplatinum

EU-0100918

Lederplatin

Neoplatin

Peyrone's chloride

Peyrone's salt

Plastin

Platamine

Platiblastin

Platidiam

Platinex

Platinol

Platinol-AQ

Platinoxan

Platinum Ammine Chloride

Platinum Ammonium Chloride

Platinum Diamine Dichloride

Randa

Trans-DDP

Trans-Diaminedichloroplatinum

Trans-Diamminedichloroplatinum

Trans-Dichlorodiammine Platinum

Trans-Platinumdiammine Dichloride

cis-DDP

cis-Diamminedichloroplatinum

cis-Dichlorodiammineplatinum(II)

cis-[PtCl2(NH3)2]

cis-diamminedichloridoplatinum(II)

cis-diamminedichloroplatinum(II)

nchembio773-comp1

trans-diamminedichloridoplatinum(II)

Octreotide

approved, investigational

Phase 2, Phase 3, Phase 1

213

83150-76-9

383414, 6400441

Synonyms:

(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide

10-(4-Aminobutyl)-19-((2-amino-3-phenylpropanoyl)amino)-16-benzyl-7-(1-hydroxyethyl)-N-(2-hydroxy-1-(hydroxymethyl)propyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaa

10-(4-aminobutyl)-19-[(2-amino-3-phenylpropanoyl)amino]-16-benzyl-N-(1,3-dihydroxybutan-2-yl)-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide

10-(4-aminobutyl)-19-[(2-amino-3-phenylpropanoyl)amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide

79517-01-4 (acetate salt)

83150-76-9

AC1L1GVU

AC1L8LCD

AC1L9M4X

C07306

C5H12O2.C4H10

CHEBI:427278

CHEBI:611465

CHEMBL1680

CID383414

CID448601

CID54374

D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-L-threoninol cyclic (2-7)-disulfide

D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-((1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl)-L-cysteinamide cyclic (2-7)-disulfide

D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-((1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl)-L-cysteinamide cyclic (2->7)-disulfide

D00442

DRG-0115

HMS2090C09

HS-2020

L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L- threonyl-N-(2-hydroxy-1-(hydroxymethyl)propyl)-, cyclic (2->7)-disulfide, (R-(R*

L000453

LS-177735

LS-187135

Longastatin

NCGC00181796-01

NCI60_025753

Octreotida

Octreotida [Spanish]

Octreotide

Octreotide (USAN/INN)

Octreotide Acetate Salt

Octreotide [USAN:INN:BAN]

Octreotide-LAR

Octreotidum

Octreotidum [Latin]

Octrotide

SAN 201-995

SM 201-995

SMS 201-995

SMS-201-995

Sandostatine

Sandoz 201-995

UNII-RWM8CCW8GP

nchembio.184-comp3

zacycloicosane-4-carboxamide acetate

lanreotide

approved

Phase 2, Phase 3

108736-35-2

Synonyms:

Lanreotide

Lanreotide acetate

Somatuline Depot

Progesterone

approved, vet_approved

Phase 3, Phase 2, Phase 1, Early Phase 1

537

57-83-0

5994

Synonyms:

(S)-4-Pregnene-3,20-dione

(S)-Pregn-4-en-3,20-dione

(S)-Progesterone

.beta.-Progesterone

.delta.(sup4)-Pregnene-3,20-dione

.delta.4-Pregnene-3,20-dione

17.alpha.-Progesterone

17a-Progesterone

17alpha-Progesterone

17alpha-progesterone

17α-progesterone

1dbb

1h60

257630-50-5

3,20-Pregnene-4

32104FB6-BF81-4F6E-83C2-024DEEAEB272

4-Pregnen-3,20-dione

4-Pregnene-3,20-dione

46665_FLUKA

46665_RIEDEL

57-83-0

753497-20-0

8012-32-6

8023-13-0

AC-700

AC1L1LKF

AI3-51682

Agolutin

Akrolutin

BB_NC-0185

BHR-100

BIDD:ER0547

BIDD:PXR0094

BPBio1_000676

BRD-K64994968-001-03-6

BSPBio_000614

Bio-luton

C00410

CCRIS 533

CHEBI:17026

CHEMBL103

CID5994

CIDR

CMC_13406

COL-1620

CPD000058345

Colprosterone

Corlutin

Corlutina

Corluvite

Corporin

Corpus Luteum Hormone

Corpus luteum hormone

Crinone

Crinone (TN)

Crinone progesterone gel

Curretab

Cyclogest

Cyclogesterin

D00066

D4-Pregnene-3,20-dione

DB00396

DR-2011

Delalutin

Delta(4)-pregnene-3,20-dione

Duraprogen

EINECS 200-350-6

ETI-411

EU-0100895

Endometrin

Estima

FE-999913

Flavolutan

Fologenon

Gelbkoerperhormon

Gesterol

Gesterol 100

Gesterol 50

Gestiron

Gestone

Gestormone

Gestron

Glanducorpin

Gynlutin

Gynoluton

Gynolutone

HMS1569O16

HMS2051O05

HMS2090J07

HSDB 3389

Hormoflaveine

Hormoluton

Hydroxyprogesterone Caproate

Hydroxyprogesterone Caproic acid

LMST02030159

LS-234

Lingusorbs

Lipo-Lutin

Lipolutin

Lopac0_000895

Lucorteum

Lucorteum Sol

Lucorteum sol

Lugesteron

Luteal hormone

Luteinique

Luteocrin normale

Luteodyn

Luteogan

Luteohormone

Luteol

Luteol (VAN)

Luteopur

Luteosan

Luteostab

Luteovis

Luteum

Lutex

Lutidon

Lutin

Lutinus

Lutociclina

Lutocuclin M

Lutocyclin

Lutocyclin M

Lutocyclin m

Lutocylin

Lutocylol

Lutoform

Lutogyl

Lutogynon

Lutren

Lutromone

MLS000028517

MLS000758277

MLS001074187

MLS002222367

MPA

Membrettes

Methylpregnone

Micronized Progesterone

MolPort-001-794-643

NCGC00022185-03

NCGC00022185-04

NCGC00022185-05

NCGC00022185-06

NCGC00022185-07

NCGC00022185-08

NCGC00022185-09

NCGC00090798-01

NCGC00090798-02

NCI60_042166

NSC 64377

NSC 9704

NSC-9704

NSC64377

NSC9704

Nalutron

Natural Progesterone

P 0130

P0130_SIGMA

P0478

P3972_SIGMA

P6149_SIGMA

P7556_ALDRICH

P7556_SIGMA

P8783_SIGMA

P9776_SIGMA

PROGESTERONE

Percutacrine

Percutacrine Luteinique

Piaponon

Pranone

Pregn-4-en-3,20-dione

Pregn-4-ene-3,20-dione

Pregnene-3,20-dione

Pregnenedione

Prestwick0_000477

Prestwick1_000477

Prestwick2_000477

Prestwick3_000477

Prestwick_411

Primolut

Prochieve

Progeffik

Progekan

Progestan

Progestasert

Progesterol

Progesteron

Progesterona

Progesterona [INN-Spanish]

Progesterone

Progesterone (JP15/USP/INN)

Progesterone [INN:BAN:JAN]

Progesterone [Progestins]

Progesterone, water-soluble

Progesterone-Water Soluble

Progesterone: HBC complex

Progesteronum

Progesteronum [INN-Latin]

Progestin

Progestogel

Progestol

Progeston

Progestone

Progestosol

Progestrel

Progestron

Progestronol

Progestérone

Projestaject

Prolets

Prolidon

Prolutin

Proluton

Prolutone

Prometrium

Prometrium (TN)

Prontogest

Protormone

S00293

S1705_Selleck

SAM001247039

SMR000058345

SMR000653542

SPBio_002553

SR-01000000088

SR-01000000088-5

Spectrum5_002053

Syngesterone

Syngestrets

Synovex S

Syntolutan

U 3672

UNII-4G7DS2Q64Y

Utrogest

Utrogestan

Vitarrine

WLN: L E5 B666 OV MUTJ A1 E1 FV1

ZINC04428529

beta-Progesterone

bmse000482

component of Cyclogesterin

corpus luteum hormone

delta(4)-Pregnene-3,20-dione

delta(Sup 4)-Pregnene-3,20-dione

delta(Sup4)-pregnene-3,20-dione

delta(sup 4)-Pregnene-3,20-dione

delta4-Pregnene-3,20-dione

luteohormone

nchembio.2007.53-comp14

Cetuximab

approved

Phase 3, Phase 1, Phase 2

737

205923-56-4

56842117, 2333

Synonyms:

205923-56-4

Anti EGFR

Cetuximab

Cetuximab (USAN/INN)

Cetuximab (genetical recombination)

Cetuximab (genetical recombination) (JAN)

Cetuximabum

Cétuximab

D03455

Erbitux

Erbitux (TN)

IMC-C225

Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer

cetuximab

Fentanyl

approved, illicit, investigational, vet_approved

Phase 3

773

437-38-7

3345

Synonyms:

1-Phenethyl-4-(N-phenylpropionamido)piperidine

1-Phenethyl-4-N-propionylanilinopiperidine

1-phenethyl-4-N-propionylanilinopiperidine

437-38-7

5-22-08-00049 (Beilstein Handbook Reference)

80832-90-2

990-73-8 (citrate)

AC1L1FQ2

Actiq

BIDD:GT0555

BRN 0494484

CHEBI:119915

CHEMBL596

CID3345

D00320

DB00813

Duragesic

Duragesic (TN)

Duragesic-100

Duragesic-12

Duragesic-25

Duragesic-50

Duragesic-75

Durogesic

EINECS 207-113-6

Fentanest

Fentanil

Fentanil [DCIT]

Fentanila

Fentanila [INN-Spanish]

Fentanilo

Fentanyl

Fentanyl (JAN/USAN/INN)

Fentanyl CII

Fentanyl [INN:BAN]

Fentanyl citrate

Fentanyl-100

Fentanyl-12

Fentanyl-25

Fentanyl-50

Fentanyl-75

Fentanylum

Fentanylum [INN-Latin]

HSDB 3329

IONSYS

JNS020QD

L001275

LS-124439

Matrifen

MolPort-003-847-369

N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide

N-(1-Phenethyl-4-piperidyl)propionanilide

N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide

N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide

N-(1-phenethyl-4-piperidinyl)-N-phenylpropionamide

N-(1-phenethyl-4-piperidyl)propionanilide

N-(1-phenethylpiperidin-4-yl)-N-phenylpropanamide

N-(1-phenethylpiperidin-4-yl)-N-phenylpropionamide

N-Phenethyl-4-(N-propionylanilino)piperidine

N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide

N-phenethyl-4-(N-propionylanilino)piperidine

N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide

N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide

NCGC00168252-01

Nasalfent

Oprea1_152073

Oprea1_207148

PDSP1_000860

PDSP2_000846

Pentanyl

Phentanyl

Propanamide, N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)- (9CI)

R 4263

Rapinyl

Sentonil

Sublimase

Sublimaze

UNII-UF599785JZ

fentanyl

Metformin

approved

Phase 3, Phase 2, Phase 1

1746

657-24-9

14219, 4091

Synonyms:

1,1-Dimethyl biguanide

1,1-Dimethylbiguanide

3-(diaminomethylidene)-1,1-dimethylguanidine

657-24-9

AC1L1HE4

AKOS000121065

Apo-Metformin

BIDD:GT0697

BPBio1_000009

BRD-K79602928-003-04-1

BSPBio_000007

BSPBio_002314

C07151

C4H11N5

CAS-1115-70-4

CCRIS 9321

CHEBI:6801

CHEMBL1431

CID4091

D04966

DB00331

DMGG

Diabetosan

Diabex

Dimethylbiguanid

Dimethylbiguanide

Dimethylbiguanidine

Dimethyldiguanide

Dimethylguanylguanidine

EINECS 211-517-8

Fluamine

Flumamine

Fortamet

Gen-Metformin

Glifage

Gliguanid

Glucophage

Glucophage XR

Glumetza

Glycon

HMS2089D19

HSCI1_000295

Haurymelin

Haurymellin

Islotin

KBio2_002310

KBio2_004878

KBio2_007446

KBio3_002790

KBioGR_002310

KBioSS_002312

LA-6023

LS-43899

Melbin

Metformin

Metformin (USAN/INN)

Metformin HCL

Metformin [USAN:INN:BAN]

Metformina

Metformina [DCIT]

Metformina [Spanish]

Metformine

Metformine [INN-French]

Metformine pamoate

Metforminum

Metforminum [INN-Latin]

Metiguanide

MolPort-002-929-560

MolPort-004-288-389

MolPort-005-767-418

Mylan-Metformin

N,N-Dimethylbiguanide

N,N-Dimethyldiguanide

N,N-Dimethylimidodicarbonimidic diamide

N,N-dimethylimidodicarbonimidic diamide

N1,N1-Dimethylbiguanide

NCGC00016564-01

NCGC00016564-02

NCGC00016564-03

NNDG

Novo-Metformin

Nu-Metformin

PMS-Metformin

Prestwick0_000004

Prestwick1_000004

Prestwick2_000004

Prestwick3_000004

Ran-Metformin

Ratio-Metformin

Riomet

S2483_Selleck

SPBio_001928

STK011633

Sandoz Metformin

Siofor

T5895664

Teva-Metformin

UNII-9100L32L2N

ZINC12859773

cMAP_000016

metformin

metformin hydrochloride

Prednisone

approved, vet_approved

Phase 3

1359

53-03-2

5865

Synonyms:

(1S,2R,10S,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,17-dione

(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione

(8xi,9xi,14xi)-17,21-dihydroxypregna-1,4-diene-3,11,20-trione

.delta. E

.delta.(sup1)-Cortisone

.delta.-Cortelan

.delta.-Cortisone

.delta.-Cortone

.delta.-E

.delta.1-Cortisone

.delta.1-Dehydrocortisone

.delta.sone

1,2-Dehydrocortisone

1,4-Pregnadiene-17-alpha,21-diol-3,11,20-trione

1,4-Pregnadiene-17.alpha.,21-diol-3,11,20-trione

1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione

1-Cortisone

1-Dehydrocortisone

17,21-Dihydroxypregna-1,4-diene-3,11,20-trione

17alpha,21-Dihydroxy-1,4-pregnadiene-3,11,20-trione

53-03-2

68-59-7

81552_FLUKA

AC-11112

AC1L1LB2

AC1Q29EZ

ACon0_000082

ACon1_000297

AI3-52939

Adasone

Ancortone

Apo-Prednisone

Apo-prednisone

BPBio1_000323

BRD-K85883481-001-04-2

BSPBio_000293

Betapar

Bicortone

Bio-0649

C07370

C21H26O5

CCRIS 2646

CHEBI:8382

CHEMBL635

CID5865

CPD001227202

Cartancyl

Colisone

Cortan

Cortancyl

Cortidelt

Cotone

DB00635

Dacorten

Dacortin

Decortancyl

Decortin

Decortisyl

Dehydrocortisone

Dekortin

Delcortin

Dellacort

Dellacort A

Delta Cortelan

Delta E

Delta E.

Delta-Cortelan

Delta-Dome

Delta-cortelan

Delta-cortisone

Delta-cortone

Delta-dome

Deltacortene

Deltacortisone

Deltacortone

Deltasone

Deltasone, Liquid Pred, Orasone, Adasone, Deltacortisone,Prednisone

Deltison

Deltisona

Deltisone

Deltra

Di-Adreson

Diadreson

EINECS 200-160-3

Econosone

Encorton

Encortone

Enkortolon

Enkorton

Fernisone

Fiasone

HMS1568O15

HMS2090J13

HSDB 3168

Hostacortin

In-Sone

Incocortyl

Juvason

Kortancyl

LMST02030180

LS-1325

Liquid Pred

Lisacort

Lodotra

MEGxm0_000443

MLS001061265

MLS001304073

MLS001335907

MLS001335908

MLS002154191

MLS002207083

Me-Korti

Metacortandracin

Meticorten

Meticorten (Veterinary)

Metrevet (Veterinary)

MolPort-001-740-041

NCGC00090766-01

NCGC00090766-02

NCGC00090766-03

NCI-C04897

NCI60_000008

NSC 10023

NSC10023

Nisona

Nizon

Novoprednisone

Nurison

Orasone

Origen Prednisone

P1276

P6254_SIGMA

PRD

Panafcort

Panasol

Paracort

Parmenison

Pehacort

Precort

Predeltin

Prednicen-M

Prednicorm

Prednicort

Prednicot

Prednidib

Prednilonga

Prednison

Prednisona

Prednisona [INN-Spanish]

Prednisone

Prednisone Intensol

Prednisone [INN:BAN]

Prednisonum

Prednisonum [INN-Latin]

Prednitone

Prednizon

Prednovister

Presone

Prestwick0_000077

Prestwick1_000077

Prestwick2_000077

Prestwick3_000077

Prestwick_405

Pronison

Pronisone

Rectodelt

Retrocortine

S1622_Selleck

SAM002264641

SK-Prednisone

SMR000718760

SMR001227202

SPBio_002214

Servisone

Sone

Sterapred

Supercortil

U 6020

UNII-VB0R961HZT

Ultracorten

Ultracortene

WLN: L E5 B666 CV OV AHTTT&J A1 E1 FV1Q FQ

Winpred

Wojtab

ZINC03875357

Zenadrid

Zenadrid (veterinary)

Zenadrid [veterinary]

delta cortelan

delta(sup 1)-Cortisone

delta(sup 1)-Dehydrocortisone

delta-1-Cortisone

delta-1-Dehydrocortisone

delta-Cortisone

delta-Cortone

Doxorubicin

approved, investigational

Phase 2, Phase 3, Phase 1

1714

23214-92-8

31703

Synonyms:

(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside

(8S-cis)-10-((3-amino-2,3,6-Trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione

111266-55-8

14-Hydroxydaunomycin

14-Hydroxydaunorubicine

14-hydroxydaunomycin

14-hydroxydaunorubicine

23214-92-8

23257-17-2

24385-08-8

25311-50-6

25316-40-9

25316-40-9 (hydrochloride)

29042-30-6

AC1L1M5T

AC1Q29OJ

ADM

ADR

Adriablastin

Adriacin (hydrochloride salt)

Adriamycin

Adriamycin PFS

Adriamycin PFS (hydrochloride salt)

Adriamycin RDF

Adriamycin RDF (hydrochloride salt)

Adriamycin Semiquinone

Adriamycin semiquinone

Adriblas tina

Adriblastin

Adriblastina

Adriblastina (TN)

Adriblastina (hydrochloride salt)

Aerosolized Doxorubicin

BPBio1_000502

BRD-K92093830-003-04-3

BSPBio_000456

BSPBio_001031

C01661

C27H29NO11

CCRIS 739

CHEBI:28748

CHEMBL179

CID31703

Caelyx

Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74

Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120

D03899

DB00997

DM2

DOX-SL

Doxil

Doxo

Doxorubicin

Doxorubicin (USAN/INN)

Doxorubicin HCl

Doxorubicin Hydrochloride

Doxorubicin [USAN:INN:BAN]

Doxorubicin citrate

Doxorubicin hydrochloride (hydrochloride salt)

Doxorubicin-P4/D10

Doxorubicin-P4/D10 conjugate

Doxorubicin-hLL1

Doxorubicin-hLL1 conjugate

Doxorubicina

Doxorubicina [INN-Spanish]

Doxorubicine

Doxorubicine [INN-French]

Doxorubicinum

Doxorubicinum [INN-Latin]

EINECS 245-495-6

FI 106

Farmablastina (hydrochloride salt)

HMS2089H06

HSDB 3070

Hydroxydaunomycin hydrochlor ide (hydrochloride salt)

Hydroxydaunomycin hydrochloride (hydrochloride salt)

Hydroxydaunorubicin

Hydroxydaunorubicin hydrochloride (hydrochloride salt)

JT9100000

LMPK13050001

LS-1029

LS-165655

MLS000759533

Myocet

NCI-C01514

NChemBio.2007.10-comp13

NDC 38242-874

NIOSH/JT9100000

NSC 123127

Prestwick0_000438

Prestwick1_000438

Prestwick2_000438

Prestwick3_000438

Probes1_000151

Probes2_000129

RDF Rubex

Resmycin

Rubex

Rubex (hydrochloride salt)

SMP1_000106

SPBio_002395

TLC D-99

ThermoDox

Triferric doxorubicin

UNII-80168379AG

adiblastine (hydrochloride salt)

adr iablatina (hydrochloride salt)

adriablastine (hydrochloride salt)

adriablatina (hydrochloride salt)

adriblatina (hydrochloride salt)

doxorubicin

nchembio809-comp5

Anastrozole

approved, investigational

Phase 3, Phase 2

272

120511-73-1

2187

Synonyms:

.alpha.,alpha.,.alpha.',.alpha.'-tetramethyl-5(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile

1,3-benzenediacetonitrile, a, a, a', a'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)

120511-73-1

2,2'-(5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene)bis(2-methylpropionitrile)

2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene]bis(2-methylpropanenitrile)

2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)benzene-1,3-diyl]bis(2-methylpropanenitrile)

2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanenitrile

AC-4234

AC1L1D49

Anastrazole

Anastrole

Anastrozol

Anastrozole (JAN/USAN/INN)

Anastrozole [USAN:INN:BAN]

Arimidex

Arimidex (TN)

Arimidex (Zeneca)

Arimidex, Anastrozole

Asiolex

Astra brand of anastrozole

AstraZeneca brand of anastrozole

C08159

C090450

C17H19N5

CHEBI:2704

CHEMBL1399

CID2187

CPD000466301

D00960

DB01217

HMS2052M11

HMS2089N10

HSDB 7462

I06-0021

ICI D1033

ICI-D 1033

ICI-D1033

LS-29563

MLS000759396

MLS001424217

MolPort-005-933-078

NCGC00164619-01

NSC719344

S1188_Selleck

SAM001246525

SBB066057

SMR000466301

UNII-2Z07MYW1AZ

ZD 1033

ZD-1033

ZD1033

ZINC00000941

Zeneca ZD 1033

Zeneca brand of anastrozole

alpha,alpha,Alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile

alpha,alpha,alpha',alpha'-Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile

anastrazole

anastrozole

Letrozole

approved, investigational

Phase 3, Phase 2, Phase 1

382

112809-51-5

3902

Synonyms:

1-[Bis-(4-cyanophenyl)methyl]-1,2,4-triazole

1-[bis(4-cyanophenyl)methyl]-1,2,4-triazole

112809-51-5

4,4'-((1h-1,2,4-triazol-1-yl)methylene)dibenzonitrile

4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile

4,4'-(1H-1,2,4-triazol-1-yl-methylene)-bis(benzonitrile)

4,4'-(1H-1,2,4-triazol-1-ylmethanediyl)dibenzonitrile

4,4'-(1H-1,2,4-triazol-1-ylmethylene)bis-Benzonitrile Letrozole

4,4'-(1h-1,2,4-triazol-1-ylmethylene) bis-benzonitrile

4,4'-(1h-1,2,4-triazol-1-ylmethylene)bis-benzonitrile

4,4'-(1h-1,2,4-triazol-1-ylmethylene)bisbenzonitrile

4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile

AB00514009

AC-1193

AC1L1GYT

AKOS005145822

BIDD:GT0015

BIDD:PXR0130

BPBio1_001331

BRD-K88789588-001-03-2

BSPBio_001209

Bio-0057

C067431

C08163

C17H11N5

CAS-112809-51-5

CCRIS 8822

CGS 20267

CGS 20267, Femara, Piroxicam, Letrozole

CGS-20267

CHEBI:6413

CHEMBL1444

CID3902

CPD000466343

D00964

DB01006

FEM-345

Femara

Femara (TN)

Femera

HMS1571M11

HMS2051E08

HMS2089L22

HSDB 7461

I06-0022

LS-38788

Letoval

Letrozol

Letrozole

Letrozole (JAN/USP/INN)

Letrozole [USAN:INN]

MLS000759455

MLS001424038

MLS002584991

MolPort-003-848-373

NCGC00016973-01

NCGC00016973-02

NSC719345

Novartis Brand of Letrozole

Prestwick0_001025

Prestwick1_001025

Prestwick2_001025

Prestwick3_001025

S1235_Selleck

SAM001246649

SMR000466343

SPBio_003070

TL8000371

UNII-7LKK855W8I

ZINC03778874

letrozole

Dactinomycin

approved

Phase 3

50-76-0

2019, 457193

Synonyms:

(- )-actinomycin d

(-)-actinomycin d

-pentone

01815_FLUKA

1H-Pyrrolo(2,1-1)-(1,4,7,10,13)oxatetraazacyclohexadecine

2-amino-N,N'-bis(hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo(2,1-I)(1,4,7,10,13)oxatetra-azacyclohexadecin-10-yl)-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide

4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide

50-76-0

A1410_SIGMA

A4262_SIGMA

A9415_SIGMA

AC1L1CQX

AC1L9W52

ACT

ACT D

ACTINOMYCIN D

ACTINOMYCIN D AMP

ACTINOMYCIN-D

ACTO-D

ACon0_000471

ACon1_001004

AD (VAN)

AI3-26374

ActD

Actactinomycin A IV

Actactinomycin a Iv

Actinomycin 11 Cosmegen

Actinomycin 11 cosmegen

Actinomycin 7

Actinomycin A IV

Actinomycin Aiv

Actinomycin C (sub1)

Actinomycin C(sub1)

Actinomycin C1

Actinomycin D

Actinomycin D (JP15)

Actinomycin D deriv. of 3H-phenoxaocardazine

Actinomycin D, sodium deoxyribonucleic acid complex

Actinomycin I

Actinomycin I (sub1)

Actinomycin I(sub 1)

Actinomycin I(sub1)

Actinomycin I1

Actinomycin IV

Actinomycin Iv

Actinomycin X 1

Actinomycin X1

Actinomycin iv

Actinomycin-(threo-val-pro-sar-meval)

Actinomycin-?IV

Actinomycin-[threo-val-pro-sar-meval]

Actinomycindioic D Acid, Dilactone

Actinomycindioic D acid, dilactone

Acto-D

Antibiotic From Streptomyces Parvullus

Antibiotic from Streptomyces parvullus

BCBcMAP01_000155

BRD-A42383464-001-02-2

Bio1_000342

Bio1_000831

Bio1_001320

C06770

C62H86N12O16

CBiol_002056

CCRIS 9

CHEBI:123721

CHEBI:27666

CHEMBL1554

CHEMBL427947

CID2019

CID457193

COSMEGEN (TN)

CPD000469227

Chounghwamycin B

Cosmegen

D Actinomycin

D00214

DACTINOMYCIN

DB00970

DVA-DPR-SAR-MVA-(c1)DTH-PXZ-(c11)DTH-DVA-DPR-SAR-MVA

Dactinomicina

Dactinomicina [INN-Spanish]

Dactinomycin

Dactinomycin (USP)

Dactinomycin D

Dactinomycin [USAN:BAN]

Dactinomycine

Dactinomycine [INN-French]

Dactinomycinum

Dactinomycinum [INN-Latin]

Dilactone Actinomycin D Acid

Dilactone Actinomycindioic D Acid

Dilactone actin omycindioic D acid

Dilactone actinomycin D acid

Dilactone actinomycindioic D acid

EINECS 200-063-6

FT-0080366

GNF-PF-1977

HBF 386

HBF 386 Meractinomycin

HBF 386 meractinomycin

HMS2052O17

HSDB 3220

LMPK14000005

LS-142

Lyovac Cosmegen

Lyovac cosmegen

MEGxm0_000350

MLS001424196

Meractinomycin

MolPort-001-739-741

MolPort-003-925-177

NCGC00025059-02

NCGC00090796-01

NCGC00161622-01

NCGC00161622-02

NCGC00169767-01

NCI-C04682

NCI60_030539

NP-005932

NSC 3053

NSC-3053

NSC191297

NSC3053

Neuro_000003

Oncostatin K

Oxamide

PXZ-THR-DVA-PRO-SAR-MVA-THR-DVA-PRO-SAR-MVA

SAM001246846

SMP1_000005

SMR000469227

UNII-1CC1JFE158

UPCMLD-DP055

UPCMLD-DP055:001

UPCMLD-DP055:002

WLN: 16- AN FVN IVN LVO PVM SVTJ G1 J1 KY1&1 N1 RY1&1

X 97

actd

actinomycin D

actinomycin cl

actinomycin x i

actinomyein-theo-val-pro-sar-meval

dactinomyein d

o)-(1-oxo-1,2-ethanediyl)]bis(N-methyl)L-valine

Oxybutynin

approved, investigational

Phase 3

5633-20-5

4634

Synonyms:

1508-65-2 (hydrochloride)

4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester

4-(diethylamino)-2-butynyl-alpha-cyclohexyl-alpha-hydroxybenzeneacetate

4-(diethylamino)-2-butynyl-alpha-phenylcyclohexaneglycolate

4-(diethylamino)but-2-yn-1-yl cyclohexyl(hydroxy)phenylacetate

4-(diethylamino)but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate

4-Diethylamino-2-butinyl alpha-cyclohexylmandelat

4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate

5633-20-5

AC-2153

AC1L1ILV

BPBio1_000214

BRD-A65013509-003-03-8

BSPBio_000194

Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester

C07360

CCRIS 1923

CHEBI:7856

CHEMBL1231

CID4634

Cyclohexaneglycolic acid, .alpha.-phenyl-, 4-(diethylamino)-2-butynyl ester

Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester

Cystrin

D00465

DB01062

Ditropan

Ditropan, Lyrinel XL, Oxytrol, Oxybutynin

FT-0082890

HSDB 3270

I06-2117

L000923

LS-28714

Lopac0_000923

MolPort-003-849-741

NCGC00015767-06

NCGC00089795-02

Oxibutinina

Oxibutinina [INN-Spanish]

Oxibutyninum

Oxybutinin

Oxybutynin

Oxybutynin (USAN/INN)

Oxybutynin Base

Oxybutynin Chloride

Oxybutynin Hydrochloride

Oxybutynin [USAN:INN:BAN]

Oxybutynin topical gel

Oxybutynine

Oxybutynine [INN-French]

Oxybutyninum

Oxybutyninum [INN-Latin]

Oxytrol

Oxytrol (TN)

Pollakisu

Prestwick0_000287

Prestwick1_000287

Prestwick2_000287

Prestwick3_000287

S1754_Selleck

SPBio_002413

Transdermal patch

UNII-K9P6MC7092

oxybutynin

oxybutynin topical gel

transdermal patch

Goserelin

approved

Phase 2, Phase 3

229

65807-02-5

47725, 5311128

Synonyms:

(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[(carbamoylamino)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide

AC1NSK1T

CID5311128

Goserelin

Goserelin acetate

HMS2089D16

HS-2015

ICI-118630

MolPort-006-823-831

ZD-9393

Zoladex

goserelin

Methotrexate

approved

Phase 3, Phase 1, Phase 2

1518

1959-05-2, 59-05-2

126941

Synonyms:

4-amino-10-methylfolic acid

4-amino-N(10)-Methylpteroylglutamic acid

Abitrexate

Amethopterin

Amethopterine

Antifolan

Arbitrexate

Emtexate

Folex

HDMTX

L-Amethopterin

Ledertrexate

MTX

Metatrexan

Methopterin

Methotextrate

Methotrate

Methotrexat

Methotrexate Sodium

Methotrexatum

Methylaminopterin

Methylaminopterinum

Metotrexato

Mexate

Méthotrexate

N-Bismethylpteroylglutamic Acid

N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid

Rheumatrex

Trexall

Celecoxib

approved, investigational

Phase 2, Phase 3

435

169590-42-5

2662

Synonyms:

169590-42-5

184007-95-2

1oq5

4-(5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide

4-[5-(4-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZENESULFONAMIDE

4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1Hpyrazol-1-yl] benzenesulfonamide

4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide

AC-4228

AC1L1E6K

AI-525

BIDD:GT0408

BRD-K02637541-001-02-4

BSPBio_003596

Benzenesulfonamide,4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)

C07589

C105934

C17H14F3N3O2S

CCRIS 8679

CEL

CEP-33222

CHEBI:41423

CHEMBL118

CID2662

CPD000550473

Celebra

Celebrex

Celebrex (TN)

Celebrex, Celebra, Celecoxib

Celecox

Celecoxi

Celecoxib

Celecoxib (JAN/USAN/INN)

Celecoxib (SC-58635)

Celecoxib [Old RN]

Celecoxib [USAN]

Celecoxibum

Celocoxib

Célécoxib

D00567

DB00482

DivK1c_000893

Eurocox

FT-0080064

HMS1922G14

HMS2089L18

HMS2093I07

HMS502M15

HSDB 7038

I01-1033

IDI1_000893

KBio1_000893

KBio2_000912

KBio2_002351

KBio2_003480

KBio2_004919

KBio2_006048

KBio2_007487

KBio3_002830

KBio3_003037

KBioGR_000723

KBioGR_002351

KBioSS_000912

KBioSS_002354

LS-31667

MLS001165684

MLS001195656

MLS001304708

Medicoxib

MolPort-002-885-815

NCGC00091455-01

NCGC00091455-02

NCGC00091455-03

NCGC00091455-04

NCI60_041049

NINDS_000893

NSC719627

Onsenal

P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide

Pfizer brand of celecoxib

S1261_Selleck

SAM002589995

SC 58635

SC-58553, SC-58635

SC-58635

SC58635

SMR000550473

SPBio_001512

SPECTRUM1503678

Solexa

Spectrum2_001576

Spectrum3_001996

Spectrum4_000182

Spectrum5_001324

Spectrum_000432

TL8001323

TPI-336

UNM-0000305813

Xilebao

YM 177

YM-177

YM177

ZINC02570895

cMAP_000027

celecoxib

p-(5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide

Succinylcholine

approved

Phase 3, Phase 2, Phase 1

161

306-40-1

5314

Synonyms:

2,2'-[(1,4-DIOXOBUTANE-1,4-DIYL)BIS(OXY)]BIS(N,N,N-TRIMETHYLETHANAMINIUM)

2,2'-[(1,4-DIOXOBUTANE-1,4-diyl)bis(oxy)]bis(N,N,N-trimethylethanaminium)

2ha2

2ha6

306-40-1

4-04-00-01451 (Beilstein Handbook Reference)

541-19-5 (diiodide)

55-94-7 (dibromide)

71-27-2 (dichloride)

AC1L1K2T

Anectine

BRN 1805311

C07546

C14H30N2O4

CHEBI:45652

CHEMBL703

CID5314

Choline, succinate (2:1) (ester)

Choline, succinate (ester)

DB00202

Diacetylcholine

Dicholine succinate

Ditilin

Ditiline

HMS2090P14

HSDB 3254

InChI=1/C14H30N2O4/c1-15(2,3)9-11-19-13(17)7-8-14(18)20-12-10-16(4,5)6/h7-12H2,1-6H3/q+2

L000926

LS-53328

Listenon

Lopac-S-8251

Lopac0_001080

Lysthenon

MolPort-002-964-486

NCGC00015971-01

NCGC00015971-03

NCGC00162336-01

Quelicin

Quelicin Preservative Free

SCK

ST50437287

STK177290

Scoline

Succicuran

Succinic acid, diester with choline

Succinic acid, diester with choline chloride

Succinocholine

Succinoylcholine

Succinyl choline

Succinylbischoline

Succinylcholine

Succinylcholine Chloride

Succinyldicholine

Sucostrin

Suxamethonium

Suxamethonium chloride

UNII-J2R869A8YF

ZINC01530820

succinylcholine

succinyldicholine

trimethyl-[2-[4-oxo-4-(2-trimethylazaniumylethoxy)butanoyl]oxyethyl]azanium diio

trimethyl-[2-[4-oxo-4-[2-(trimethylazaniumyl)ethoxy]butanoyl]oxyethyl]azanium

Trametinib

approved

Phase 2, Phase 3, Phase 1

121

871700-17-3

11707110

Synonyms:

GSK 1120212

GSK1120212

JTP 74057

JTP-74057

MEK Inhibitor GSK1120212

Mekinist

Trametinib Dimethyl Sulfoxide

Trametinibum

trametinib

Lidocaine

approved, vet_approved

Phase 3

1226

137-58-6

3676

Synonyms:

.alpha.-(Diethylamino)-2,6-acetoxylidide

.alpha.-Diethylamino-2,6-dimethylacetanilide

.alpha.-Diethylaminoaceto-2,6-xylidide

.omega.-Diethylamino-2,6-dimethylacetanilide

137-58-6

2-(Diethylamino)-2',6'-acetoxylidide

2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide

2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide

2-Diethylamino-N-(2,6-dimethylphenyl)acetamide

4-12-00-02538 (Beilstein Handbook Reference)

6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE))

6108-05-0 (mono-hydrochloride, mono-hydrate)

73-78-9 (mono-hydrochloride)

AB00053581

AC-10282

AC1L1GGQ

AC1Q2Z7J

AKOS001026768

ARONIS23855

After Burn Double Strength Gel

After Burn Double Strength Spray

After Burn Gel

After Burn Spray

Alphacaine

Anestacon

Anestacon Jelly

BIDD:GT0342

BPBio1_000197

BRD-K52662033-001-02-6

BRD-K52662033-003-05-5

BRN 2215784

BSPBio_000179

BSPBio_001359

BSPBio_003004

Bio-0767

Bio1_000379

Bio1_000868

Bio1_001357

Bio2_000079

Bio2_000559

C07073

C14H22N2O

CAS-73-78-9

CDS1_000283

CHEBI:6456

CHEMBL79

CID3676

CPD000058189

Cappicaine

Cito optadren

Cuivasil

D00358

DB00281

Dalcaine

Dentipatch

Dentipatch (TN)

DermaFlex

Diethylaminoaceto-2,6-xylidide

Dilocaine

DivK1c_000174

DivK1c_001323

Duncaine

EINECS 205-302-8

ELA-Max

EMBOLEX

Emla

Emla Cream

Esracaine

FT-0082378

Gravocain

HMS1791D21

HMS1989D21

HMS2051C21

HMS2089E15

HMS548M19

HSDB 3350

I01-2704

IDI1_000174

IDI1_033829

Isicaina

Isicaine

Jetocaine

KBio1_000174

KBio2_000079

KBio2_001598

KBio2_002647

KBio2_004166

KBio2_005215

KBio2_006734

KBio3_000157

KBio3_000158

KBio3_002224

KBioGR_000079

KBioGR_000599

KBioSS_000079

KBioSS_001598

L-Caine

L0156

L1026_SIGMA

L7757_SIGMA

LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE)

LIDOPEN

LQZ

LS-805

Lanabiotic

Leostesin

Lida-Mantle

Lidocaina

Lidocaina [INN-Spanish]

Lidocaine (JP15/USP/INN)

Lidocaine (VAN)

Lidocaine Carbonate

Lidocaine Hydrocarbonate

Lidocaine Monohydrochloride

Lidocaine [USAN:INN:JAN]

Lidocainum

Lidocainum [INN-Latin]

Lidocaton

Lidoderm

Lidoject-1

Lidoject-2

Lignocaine

Lignocainum

Lingocaine

Lopac-L-5647

Lopac0_000669

MLS000069724

MLS000758263

MLS001074177

Maricaine

Maybridge1_002571

MolPort-001-783-478

N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide

N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide

NCGC00015611-01

NCGC00015611-02

NCGC00015611-03

NCGC00015611-04

NCGC00015611-14

NCGC00022176-05

NCGC00022176-06

NCGC00022176-07

NCGC00022176-08

NCGC00022176-09

NINDS_000174

NSC 40030

NSC40030

Norwood Sunburn Spray

Octocaine

Octocaine-100

Octocaine-50

Prestwick0_000050

Prestwick1_000050

Prestwick2_000050

Prestwick3_000050

Remicaine

Rocephin Kit

Rucaina

S1357_Selleck

SAM001247018

SMR000058189

SPBio_001525

SPBio_002100

STK552033

Solarcaine

Solarcaine aloe extra burn relief cream

Solcain

Spectrum2_001343

Spectrum3_001392

Spectrum4_000070

Spectrum5_001549

Spectrum_001118

UNII-98PI200987

WLN: 2N2 & 1VMR B1 F1

Xilina

Xilocaina

Xilocaina [Italian]

Xllina

Xycaine

Xylestesin

Xylesthesin

Xylocain

Xylocaine

Xylocaine (TN)

Xylocaine 5% Spinal

Xylocaine CO2

Xylocaine Dental Ointment

Xylocaine Endotracheal

Xylocaine Test Dose

Xylocaine Viscous

Xylocaine-MPF

Xylocaine-MPF with Glucose

Xylocaine-Mpf

Xylocaine-Mpf with Glucose

Xylocard

Xylocitin

Xyloneural (free base)

Xylotox

Zilactin-L

Zingo

alfa-Dietilamino-2,6-dimetilacetanilide

alfa-Dietilamino-2,6-dimetilacetanilide [Italian]

alpha-Diethylamino-2,6-dimethylacetanilide

alpha-diethylamino-2,6-dimethylacetanilide

lidocaine

nchembio.65-comp16

α-diethylamino-2,6-dimethylacetanilide

Methylprednisolone

approved, vet_approved

Phase 2, Phase 3

1153

83-43-2

6741

Synonyms:

(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one

(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione

(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione

(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione

.DELTA.1-6.alpha.-Methylhydrocortisone

1-Dehydro-6alpha-methylhydrocortisone

1-dehydro-6alpha-Methylhydrocortisone

1-dehydro-6α-methylhydrocortisone

11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione

11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione

11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione

11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione

121673-01-6

4-08-00-03498 (Beilstein Handbook Reference)

46436_FLUKA

46436_RIEDEL

570-35-4

6 Methylprednisolone

6-Methylprednisolone

6-alpha-Methylprednisolone

6.alpha.-Methylprednisolone

6923-42-8

6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione

6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione

6alpha-Methylprednisolone

6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione

83-43-2

AC1L1N7A

Artisone-Wyeth

Artisone-wyeth

BPBio1_000174

BRD-K35240538-001-03-1

BRN 2340300

BSPBio_000158

Besonia

Bio-0658

CHEBI:6888

CHEMBL650

CID6741

CPD000058330

D00407

D008775

DB00959

Depo-Medrol (acetate)

Dopomedrol

EINECS 201-476-4

Esametone

Firmacort

HMS1568H20

HMS2090B13

HSDB 3127

LMST02030178

LS-118498

Lemod

M0639_SIGMA

M1665

MEPRDL

MLS000028541

MLS001148159

MLS002207191

Medesone

Medixon

Medlone 21

Medrate

Medrol

Medrol (TN)

Medrol Adt Pak

Medrol Dosepak

Medrol adt pak

Medrol dosepak

Medrol, Solu-Medrol, Medrone, Methylprednisolone

Medrone

Mesopren

Metastab

Methyleneprednisolone

Methylprednisolon

Methylprednisolone

Methylprednisolone (JP15/USP/INN)

Methylprednisolone [USAN:INN:BAN:JAN]

Methylprednisolone, 6-alpha

Methylprednisolonum

Methylprednisolonum [INN-Latin]

Metilbetasone

Metilprednisolona

Metilprednisolona [INN-Spanish]

Metilprednisolone

Metilprednisolone [DCIT]

Metilprednisolone [Dcit]

Metipred

Metrisone

Metrocort

Metysolon

Moderin

MolPort-002-528-554

NCGC00022735-03

NCI60_001657

NSC-19987

NSC19987

Nirypan

Noretona

Predni N Tablinen

Prednol- L

Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)

Prestwick0_000279

Prestwick1_000279

Prestwick2_000279

Prestwick3_000279

Prestwick_622

Promacortine

Reactenol

S1733_Selleck

SAM002589984

SMR000058330

SPBio_002377

Sieropresol

Solomet

Summicort

Suprametil

U 7532

UNII-X4W7ZR7023

Urbason

Urbasone

Wyacort

ZINC03875560

delta(1)-6alpha-Methylhydrocortisone

delta(sup 1)-6-alpha-Methylhydrocortisone

methylprednisolone

methylprenisolone

Prednisolone

approved, vet_approved

Phase 2, Phase 3

1153

50-24-8

5755

Synonyms:

(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione

.DELTA.1-Cortisol

.DELTA.1-Dehydrocortisol

.DELTA.1-Dehydrohydrocortisone

.DELTA.1-Hydrocortisone

.delta.-Cortef

.delta.-Stab

1,2-Dehydrohydrocortisone

1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione

1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol

1-Dehydrocortisol

1-Dehydrohydrocortisone

3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene

46656_FLUKA

46656_RIEDEL

50-24-8

58201-11-9

8056-11-9

AC-1773

AC1L1L2E

Ak-Pred

Ak-Tate

Alphadrol

Articulose-50

BPBio1_000164

BRD-K98039984-001-03-0

BRN 1354103

BSPBio_000148

Bio-0666

Bubbli-Pred

C07369

CCRIS 980

CHEBI:8378

CHEMBL131

CID5755

CO-Hydeltra

CPD000718761

Co-Hydeltra

Codelcortone

Cordrol

Cortalone

Cotogesic

Cotolone

D00472

D011239

DB00860

Decaprednil

Decortin H

Delcortol

Delta F

Delta(1)-dehydrohydrocortisone

Delta-Cortef

Delta-Cortef (TN)

Delta-Ef-Cortelan

Delta-Stab

Delta-stab

Deltacortenol

Deltacortril

Deltacortril Enteric

Deltahydrocortisone

Deltasolone

Deltisilone

Depo-Medrol

Derpo PD

Derpo Pd

Dexa-Cortidelt Hostacortin H

Dexa-Cortidelt hostacortin H

Di Adreson F

Di-Adreson F

Di-Adreson-F

Di-adreson F

DiAdresonF

Dicortol

Donisolone

Dydeltrone

EINECS 200-021-7

Eazolin D

Econopred

Econopred Plus

Erbacort

Erbasona

Estilsona

Fernisolone

Fernisolone P

Fernisolone-P

Flamasone

HMS1568H10

HMS2090J05

HSDB 3385

Hostacortin H

Hydeltra

Hydeltra-Tba

Hydeltrasol

Hydeltrone

Hydrodeltalone

Hydrodeltisone

Hydroretrocortin

Hydroretrocortine

I-Pred

Inflamase Forte

Inflamase Mild

K 1557

Key-Pred

Klismacort

LMST02030179

LS-7669

Lentosone

Lite Pred

M-Predrol

MLS001304083

MLS002154250

MLS002207037

Medrol

Medrol Acetate

Metacortandralone

Methylprednisolone Acetate

Meti-Derm

Meticortelone

Metreton

MolPort-002-507-147

NCGC00179649-01

NSC 9120

NSC9120

NSC9900

Neo-Delta-Cortef

Nisolone

Nor-Pred T.B.A.

Ocu-Pred

Ocu-Pred Forte

Ophtho-Tate

Orapred

P0152_SIGMA

P0637

P6004_SIGMA

PRDL

PRED-G

Panafcortelone

Paracortol

Paracotol

Pediapred

Poly-Pred

Precortalon

Precortancyl

Precortilon

Precortisyl

Pred Forte

Pred Mild

Predair

Predair A

Predair Forte

Predalone 50

Predalone T.B.A.

Predate

Predate Tba

Predate-50

Predcor-25

Predcor-50

Predcor-Tba

Predisolone Sodium Phosphate

Predne-Dome

Prednelan

Predni-Dome

Prednicen

Predniliderm

Predniretard

Prednis

Prednisolona

Prednisolona [INN-Spanish]

Prednisolone (JP15/USP/INN)

Prednisolone (anhydrous)

Prednisolone Acetate

Prednisolone Sodium Phosphate

Prednisolone Tebutate

Prednisolone [INN:BAN:JAN]

Prednisolonum

Prednisolonum [INN-Latin]

Predonin

Predonine

Prelone

Prenolone

Prestwick0_000274

Prestwick1_000274

Prestwick2_000274

Prestwick3_000274

Prestwick_404

Rolisone

S1737_Selleck

SAM002264639

SMR000718761

SPBio_002367

Scherisolon

Solone

Steran

Sterane

Sterolone

Supercortisol

UNII-9PHQ9Y1OLM

Ulacort

Ultra Pred

Ultracorten H

Ultracortene H

Ultracortene-H

Ultracortene-Hydrogen

Ultracortene-hydrogen

ZINC03833821

component of Ataraxoid

component of K-Predne-Dome

delta(1)-Cortisol

delta(1)-Dehydrocortisol

delta(1)-Dehydrohydrocortisone

delta(1)-Hydrocortisone

delta(sup 1)-Cortisol

delta(sup 1)-Dehydrocortisol

delta(sup 1)-Dehydrohydrocortisone

delta(sup 1)-Hydrocortisone

delta-dehydrocortisol

delta-dehydrohydrocortisone

delta-hydrocortisone

prednisolone

Exemestane

approved, investigational

Phase 3, Phase 1

212

107868-30-4

60198

Synonyms:

(8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylidene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione

107868-30-4

6-Methylenandrosta-1,4-diene-3,17-dione

6-Methyleneandrosta-1,4-diene-3,17-dione

6-methylideneandrosta-1,4-diene-3,17-dione

AC-2171

AC1L1SRB

AC1Q6AAZ

Ambap107868-30-4

Aromasil

Aromasin

Aromasin (TN)

Aromasin, Exemestane

Aromasine

C056516

C08162

CHEBI:4953

CHEMBL1200374

CID60198

CPD000466314

Curator_000009

D00963

DB00990

EXE

EXEMESTANE

Exemestance

Exemestane

Exemestane (JAN/USP/INN)

Exemestane [USAN:INN:BAN]

Exemestano

Exemestano [INN-Spanish]

Exemestanum

Exemestanum [INN-Latin]

FCE-24304

Fce 24304

HMS2051J04

HSDB 7463

LS-19329

MLS000759419

MLS001424062

MolPort-003-847-343

NSC713563

Nikidess

PNU-155971

Pfizer brand of exemestane

S1196_Selleck

S1196_Sellek

SAM001246574

SMR000466314

UNII-NY22HMQ4BX

ZINC03973334

exemestane

Interventional clinical trials:

(show top 50) (show all 484)

id	Name	Status	NCT ID	Phase
1	Early Assessment of the Response to Neo-adjuvant Chemotherapy in Breast Cancer Patients With FDG-PET	Completed	NCT00904410	Phase 4
2	Study of Autologous Fat Enhanced w/ Regenerative Cells Transplanted to Reconstruct Breast Deformities After Lumpectomy	Completed	NCT00616135	Phase 4
3	Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast Cancer	Completed	NCT00742222	Phase 4
4	Phase IV Trial to Evaluate Breast Brachytherapy Using the Mammosite-Ml®	Completed	NCT01448447	Phase 4
5	Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System	Recruiting	NCT01644669	Phase 4
6	Targeted Intraoperative Radiotherapy United States (TARGIT-US) Registry Trial	Recruiting	NCT01570998	Phase 4
7	Capecitabine (NX) Versus Docetaxel Plus Capecitabine (TX) as 1-line Chemotherapy on Metastatic Breast Cancer (MBC)	Unknown status	NCT01126138	Phase 3
8	Letrozole or Tamoxifen Citrate in Treating Older Postmenopausal Women Undergoing Surgery for Breast Cancer	Completed	NCT00949598	Phase 3
9	Adjuvant Epirubicin/Cytoxan Followed By A Taxane VS. Epirubicin/Taxane As Treatment For Node-Positive Breast Cancer	Completed	NCT00140075	Phase 3
10	Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer	Completed	NCT00096278	Phase 3
11	Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy	Completed	NCT00053898	Phase 3
12	Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis	Completed	NCT00243685	Phase 2, Phase 3
13	Conservative Surgery With or Without Axillary Lymphnode Removal in Treating Women With T1N0 Breast Cancer	Completed	NCT01508546	Phase 3
14	Evaluation of the Diagnostic Performance of MRI±Biopsy to Optimize Resection of Ductal Carcinoma In Situ (DCIS) Breast Cancer	Completed	NCT01112254	Phase 3
15	Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer	Completed	NCT01426880	Phase 2, Phase 3
16	Intraoperative Gamma Camera for Breast Cancer Surgery	Completed	NCT00757302	Phase 3
17	Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer	Completed	NCT00079274	Phase 3
18	Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer	Completed	NCT00262847	Phase 3
19	Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain	Completed	NCT00538850	Phase 3
20	S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy	Completed	NCT00134056	Phase 3
21	An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation	Completed	NCT00132704	Phase 3
22	GH, IGF-I and Somatostatin Analogues in Hepatocellular Carcinoma	Completed	NCT00495846	Phase 2, Phase 3
23	Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery	Completed	NCT00326898	Phase 3
24	Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer	Recruiting	NCT02488967	Phase 3
25	Randomized Controlled Trial to Assess Blockade of Voltage Gated Sodium Channels During Surgery in Operable Breast Cancer	Recruiting	NCT01916317	Phase 3
26	Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed By Surgery	Recruiting	NCT01013649	Phase 3
27	Neoadjuvant Therapy in TRIPle Negative Breast Cancer With antiPDL1	Recruiting	NCT02620280	Phase 3
28	Breast Cancer WEight Loss Study (BWEL Study)	Recruiting	NCT02750826	Phase 3
29	Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive Breast Cancer Patients	Recruiting	NCT02221999	Phase 2, Phase 3
30	A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto)	Recruiting	NCT02125344	Phase 3
31	STAMPEDE: Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy: A Multi-Stage Multi-Arm Randomised Controlled Trial	Recruiting	NCT00268476	Phase 2, Phase 3
32	Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response to Neoadjuvant Chemotherapy	Recruiting	NCT02879513	Phase 3
33	Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer	Recruiting	NCT01272037	Phase 3
34	Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery	Recruiting	NCT01953588	Phase 3
35	Metformin Hydrochloride in Patients With Atypical Hyperplasia or In Situ Breast Cancer to Placebo in Decreasing Atypical Cells in Patients With Atypical Hyperplasia or in Situ Breast Cancer	Recruiting	NCT01905046	Phase 3
36	Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer	Recruiting	NCT02101788	Phase 2, Phase 3
37	Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer	Recruiting	NCT00565851	Phase 3
38	Radiation Therapy With or Without Chemotherapy in Patients With Stage I or Stage II Cervical Cancer Who Previously Underwent Surgery	Recruiting	NCT01101451	Phase 3
39	Oxybutynin Chloride in Managing Hot Flashes	Recruiting	NCT02961790	Phase 3
40	Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer	Recruiting	NCT00499330	Phase 3
41	Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery	Recruiting	NCT01575548	Phase 3
42	Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia	Recruiting	NCT01535053	Phase 3
43	A Study to Compare Tivozanib Hydrochloride to Sorafenib in Subjects With Refractory Advanced RCC	Recruiting	NCT02627963	Phase 3
44	Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer	Active, not recruiting	NCT00005970	Phase 3
45	Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)	Active, not recruiting	NCT00310180	Phase 3
46	Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement	Active, not recruiting	NCT00869206	Phase 3
47	Spect Analysis of Cardiac Perfusion Changes After Whole Breast/Chest Wall Radiation Therapy With Active Breathing Coordinator	Active, not recruiting	NCT00321048	Phase 3
48	Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor Therapy	Active, not recruiting	NCT00556374	Phase 3
49	A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer	Active, not recruiting	NCT00887536	Phase 3
50	Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer	Active, not recruiting	NCT01196390	Phase 3

Search NIH Clinical Center for Breast Adenocarcinoma

Genetic Tests for Breast Adenocarcinoma

Sources:
²⁷GTR
See all MalaCards sources

Genetic tests related to Breast Adenocarcinoma:

id	Genetic test	Affiliating Genes
1	Breast Adenocarcinoma²⁷

Anatomical Context for Breast Adenocarcinoma

Sources:
³⁶MalaCards
See all MalaCards sources

MalaCards organs/tissues related to Breast Adenocarcinoma:

³⁶

Breast, Lung, Kidney, Liver, Colon, Prostate, Bone

Publications for Breast Adenocarcinoma

Sources:
⁵⁷PubMed
See all MalaCards sources

Articles related to Breast Adenocarcinoma:

(show top 50) (show all 298)

id	Title	Authors	Year
1	Therapeutic effects of bach1 siRNA on human breast adenocarcinoma cell line. (28092843)	Aletaha M.... Baradaran B.	2017
2	Correction for Upadhyay et al., Intracranial microcapsule chemotherapy delivery for the localized treatment of rodent metastatic breast adenocarcinoma in the brain. (26884179)		2016
3	Silencing of High Mobility Group Isoform I-C (HMGI-C) Enhances Paclitaxel Chemosensitivity in Breast Adenocarcinoma Cells (MDA-MB-468). (27478778)	Mansoori B.... Baradaran B.	2016
4	The application of the linear quadratic model to compensate the effects of prolonged fraction delivery time on a Balb/C breast adenocarcinoma tumor: An in vivo study. (26630280)	Nikzad S.... Amini P.	2016
5	Role of Glutathione System Redox Potential in Apoptosis Dysregulation in MCF-7 Breast Adenocarcinoma. (26750929)	Shakhristova E.V.... Novitskii V.V.	2016
6	Mitochondrial thiol modification by a targeted electrophile inhibits metabolism in breast adenocarcinoma cells by inhibiting enzyme activity and protein levels. (26774751)	Smith M.R.... Landar A.	2016
7	Microbial-catalysed derivatization of anti-cancer drug exemestane and cytotoxicity of resulting metabolites against human breast adenocarcinoma cell line (MCF-7) in vitro. (27521799)	Baydoun S.... Choudhary M.I.	2016
8	Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: In vitro and in vivo evaluation. (26802496)	Alibolandi M.... Hadizadeh F.	2016
9	Inhibitory and Cytotoxic Activities of Chrysin on Human Breast Adenocarcinoma Cells by Induction of Apoptosis. (27761071)	Samarghandian S.... Samini M.	2016
10	A Bowman-Birk inhibitor induces apoptosis in human breast adenocarcinoma through mitochondrial impairment and oxidative damage following proteasome 20S inhibition. (27551492)	Mehdad A.... de Freitas S.M.	2016
11	Ajwa Date (Phoenix dactylifera L.) Extract Inhibits Human Breast Adenocarcinoma (MCF7) Cells In Vitro by Inducing Apoptosis and Cell Cycle Arrest. (27441372)	Khan F.... Gauthaman K.	2016
12	SERS-active Au/SiO2 clouds in powder for rapid ex vivo breast adenocarcinoma diagnosis. (27375955)	Cepeda-PAcrez E.... de la Rosa E.	2016
13	In vitro cytotoxic effect of tyrosine kinase inhibitor sunitinib malate alone and in combination with hyperthermia on breast adenocarcinoma MCF-7 cells. (27569072)	Topcul M.R.... Cetin I.	2016
14	Phyto-synthesis of silver nanoparticles using Alternanthera tenella leaf extract: an effective inhibitor for the migration of human breast adenocarcinoma (MCF-7) cells. (26801668)	Sathishkumar P.... Palvannan T.	2016
15	Synthesis of polydopamine as a new and biocompatible coating of magnetic nanoparticles for delivery of doxorubicin in mouse breast adenocarcinoma. (27752764)	Zavareh S.... Hashemi-Moghaddam H.	2016
16	HMGI-C suppressing induces P53/caspase9 axis to regulate apoptosis in breast adenocarcinoma cells. (27245202)	Mansoori B.... Baradaran B.	2016
17	184AA3: a xenograft model of ER+ breast adenocarcinoma. (26661596)	Hines W.C.... Bissell M.J.	2016
18	Aldehyde dehydrogenase 3A1 promotes multi-modality resistance and alters gene expression profile in human breast adenocarcinoma MCF-7 cells. (27276244)	Voulgaridou G.P.... Pappa A.	2016
19	Fas-associated protein with death domain (FADD) regulates autophagy through promoting the expression of Ras homolog enriched in brain (Rheb) in human breast adenocarcinoma cells. (27013580)	He L.... Hua Z.C.	2016
20	Cambogin exerts anti-proliferative and pro-apoptotic effects on breast adenocarcinoma through the induction of NADPH oxidase 1 and the alteration of mitochondrial morphology and dynamics. (27418140)	Shen K.... Xu H.	2016
21	Inhibition of mouse breast adenocarcinoma growth by ablation with intratumoral alpha-irradiation combined with inhibitors of immunosuppression and CpG. (27495172)	Confino H.... Keisari Y.	2016
22	Utility of GATA-3 in the work-Up of breast adenocarcinoma and its differential diagnosis in serous effusions:: A Cell-Block Microarray Study. (27338760)	El Hag M.I.... Michael C.W.	2016
23	Ultrastructural Assessment of 2-(acridin-9-ylmethylene)-N-phenylhydrazinecarbothioamide activity on human breast adenocarcinoma cells. (27668344)	de Almeida S.M.... de Carvalho JA_nior L.B.	2016
24	Cytotoxicity of Manganese (III) Complex in Human Breast Adenocarcinoma Cell Line Is Mediated by the Generation of Reactive Oxygen Species Followed by Mitochondrial Damage. (27461214)	Al-Anbaky Q.... Ali N.	2016
25	In vitro evaluation of curcumin effects on breast adenocarcinoma 2D and 3D cell cultures. (25826489)	Abuelba H.... PetreuA9 T.	2015
26	Epithelial cell adhesion molecule aptamer conjugated PEG-PLGA nanopolymersomes for targeted delivery of doxorubicin to human breast adenocarcinoma cell line in vitro. (25529433)	Alibolandi M.... Hadizadeh F.	2015
27	Inhibition of the transient receptor potential melastatin-2 channel causes increased DNA damage and decreased proliferation in breast adenocarcinoma cells. (25760245)	Hopkins M.M.... Koh D.W.	2015
28	The comparison of anticancer activity of thymoquinone and nanothymoquinone on human breast adenocarcinoma. (25901162)	Dehghani H.... Mohsenifar A.	2015
29	Human Mesenchymal Stromal Cells Transplantation May Enhance or Inhibit 4T1 Murine Breast Adenocarcinoma through Different Approaches. (26000020)	Jazedje T.... Zatz M.	2015
30	Internalization and Recycling of the HER2 Receptor on Human Breast Adenocarcinoma Cells Treated with Targeted Phototoxic Protein DARPinminiSOG. (26483969)	Shilova O.N.... Deyev S.M.	2015
31	Anticancer Activity of Curcumin on Human Breast Adenocarcinoma: Role of Mcl-1 Gene. (26413251)	Khazaei Koohpar Z.... Hashemi M.	2015
32	Enhanced cytotoxicity in triple-negative and estrogen receptora89positive breast adenocarcinoma cells due to inhibition of the transient receptor potential melastatin-2 channel. (26178079)	Koh D.W.... Feng X.	2015
33	Apoptotic Effects of Two COX-2 Inhibitors on Breast Adenocarcinoma Cells Through COX-2 Independent Pathway. (25142612)	Norouzi M.... Salimi M.	2015
34	Cerebrospinal fluid cell cannibalism in metastatic breast adenocarcinoma. (26017217)	Almeida S.M.... Rotta I.	2015
35	RSK4 knockdown promotes proliferation, migration and metastasis of human breast adenocarcinoma cells. (26397146)	Zhu J.... Tang W.	2015
36	Effects of sulfated and non-sulfated I^-glucan extracted from Agaricus brasiliensis in breast adenocarcinoma cells - MCF-7. (25970150)	Baranoski A.... Mantovani M.S.	2015
37	Oxidative modification induced by photodynamic therapy with PhotofrinArII and 2-methoxyestradiol in human ovarian clear carcinoma (OvBH-1) and human breast adenocarcinoma (MCF-7) cells. (25960212)	Saczko J.... Kulbacka J.	2015
38	Targeting Cellular Metabolism Chemosensitizes the Doxorubicin-Resistant Human Breast Adenocarcinoma Cells. (26558272)	Ma S.... Shen B.	2015
39	Sonochemotherapy of breast adenocarcinoma: an experimental in vivo model. (26191104)	Yousefian B.... Mokhtari-Dizaji M.	2015
40	(6E,10E) Isopolycerasoidol and (6E,10E) Isopolycerasoidol Methyl Ester, Prenylated Benzopyran Derivatives from Pseuduvaria monticola Induce Mitochondrial-Mediated Apoptosis in Human Breast Adenocarcinoma Cells. (25946039)	Taha H.... Mohd Ali H.	2015
41	Participation of non-neuronal muscarinic receptors in the effect of carbachol with paclitaxel on human breast adenocarcinoma cells. Roles of nitric oxide synthase and arginase. (25812766)	EspaA+ol A.J.... Sales M.E.	2015
42	Evaluation of fractionated and repeated sonodynamic therapy by using dual frequency for murine model of breast adenocarcinoma. (26124951)	Alamolhoda M.... Mokhtari-Dizaji M.	2015
43	Breast adenocarcinoma recurring as small cell carcinoma in a patient with a germline BRCA2 mutation: clonal evolution unchecked. (25671134)	Niravath P.... Rimawi M.	2015
44	Quercetin protects necrotic insult and promotes apoptosis by attenuating the expression of RAGE and its ligand HMGB1 in human breast adenocarcinoma cells. (25983116)	Dhumale S.S.... Pathak C.	2015
45	Multiple molecular forms of adaptor protein Ruk/CIN85 specifically associate with different subcellular compartments in human breast adenocarcinoma MCF-7 cells. (25816594)	Vynnytska-Myronovska B.O.... Drobot L.B.	2014
46	Lipid Peroxidation and Altered Anti-oxidant Status in Breast Adenocarcinoma Patients. (25050522)	Wang C.... Wu N.	2014
47	D-Glucose-Induced Cytotoxic, Genotoxic, and Apoptotic Effects on Human Breast Adenocarcinoma (MCF-7) Cells. (25506409)	Tchounwou C.K.... Tchounwou P.B.	2014
48	XIAP inhibitor and antiestrogen embelin abrogates metastasis and augments apoptosis in estrogen receptor positive human breast adenocarcinoma cell line MCF-7. (24390234)	Sumalatha K.R.... Sreepriya M.	2014
49	Obacunone exhibits anti-proliferative and anti-aromatase activity inA vitro by inhibiting the p38 MAPK signaling pathway in MCF-7 human breast adenocarcinoma cells. (24927687)	Kim J.... Patil B.S.	2014
50	In vitro cytotoxicity screening of wild plant extracts from Saudi Arabia on human breast adenocarcinoma cells. (24938609)	Ali M.A.... Abou-Tarboush F.M.	2014

Genes related to Breast Adenocarcinoma

Sources:
⁵Clinvar, ⁸Cosmic, ¹³DISEASES, ²¹GeneCards
See all MalaCards sources

Genes related to Breast Adenocarcinoma (2 elite genes):

(show all 29)

- Elite gene

- Cancer Census gene in COSMIC

id	Symbol	Description	Score	Implication
1	PIK3CA	Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha	428.14	Pathogenic ⁵ DISEASES inferred ¹³
2	AKT1	AKT Serine/Threonine Kinase 1	404.48	Pathogenic ⁵ DISEASES inferred ¹³
3	BAX	BCL2 Associated X, Apoptosis Regulator	26.47	GeneCards inferred via : Publications, Expressions (show sections)
4	ERBB2	Erb-B2 Receptor Tyrosine Kinase 2	24.40	DISEASES inferred ¹³ GeneCards inferred via : Publications (show sections)
5	TP53	Tumor Protein P53	23.87	DISEASES inferred ¹³ GeneCards inferred via : Publications (show sections)
6	ESR1	Estrogen Receptor 1	23.63	DISEASES inferred ¹³ GeneCards inferred via : Publications (show sections)
7	TNFSF11	Tumor Necrosis Factor Superfamily Member 11	23.22	DISEASES inferred ¹³ GeneCards inferred via : Publications (show sections)
8	EGF	Epidermal Growth Factor	22.61	DISEASES inferred ¹³ GeneCards inferred via : Publications (show sections)
9	EGFR	Epidermal Growth Factor Receptor	22.29	DISEASES inferred ¹³ GeneCards inferred via : Publications (show sections)
10	TGFB1	Transforming Growth Factor Beta 1	22.08	DISEASES inferred ¹³ GeneCards inferred via : Publications (show sections)
11	MMP9	Matrix Metallopeptidase 9	21.86	DISEASES inferred ¹³ GeneCards inferred via : Publications (show sections)
12	PARP1	Poly(ADP-Ribose) Polymerase 1	21.75	DISEASES inferred ¹³ GeneCards inferred via : Publications (show sections)
13	CDKN1A	Cyclin Dependent Kinase Inhibitor 1A	21.59	DISEASES inferred ¹³ GeneCards inferred via : Publications (show sections)
14	FOS	Fos Proto-Oncogene, AP-1 Transcription Factor Subunit	21.59	DISEASES inferred ¹³ GeneCards inferred via : Publications (show sections)
15	TNF	Tumor Necrosis Factor	21.57	DISEASES inferred ¹³ GeneCards inferred via : Publications (show sections)
16	CASP8	Caspase 8	21.53	DISEASES inferred ¹³ GeneCards inferred via : Publications (show sections)
17	CYCS	Cytochrome C, Somatic	21.46	DISEASES inferred ¹³ GeneCards inferred via : Publications (show sections)
18	CTSK	Cathepsin K	21.39	DISEASES inferred ¹³ GeneCards inferred via : Publications (show sections)
19	PLAU	Plasminogen Activator, Urokinase	21.35	DISEASES inferred ¹³ GeneCards inferred via : Publications (show sections)
20	NQO1	NAD(P)H Quinone Dehydrogenase 1	21.20	DISEASES inferred ¹³ GeneCards inferred via : Publications (show sections)
21	ALDH3A1	Aldehyde Dehydrogenase 3 Family Member A1	13.40	DISEASES inferred ¹³ GeneCards inferred via : Publications (show sections)
22	WISP2	WNT1 Inducible Signaling Pathway Protein 2	11.11	DISEASES inferred ¹³ GeneCards inferred via : Publications (show sections)
23	MYC	V-Myc Avian Myelocytomatosis Viral Oncogene Homolog	11.07	DISEASES inferred ¹³ GeneCards inferred via : Publications (show sections)
24	CASP7	Caspase 7	11.05	DISEASES inferred ¹³ GeneCards inferred via : Publications (show sections)
25	CTSD	Cathepsin D	10.99	DISEASES inferred ¹³ GeneCards inferred via : Publications (show sections)
26	PXN	Paxillin	10.88	DISEASES inferred ¹³ GeneCards inferred via : Publications (show sections)
27	SPAM1	Sperm Adhesion Molecule 1	10.87	DISEASES inferred ¹³ GeneCards inferred via : Publications (show sections)
28	CYP1A1	Cytochrome P450 Family 1 Subfamily A Member 1	10.78	DISEASES inferred ¹³ GeneCards inferred via : Publications (show sections)
29	SH3KBP1	SH3 Domain Containing Kinase Binding Protein 1	10.67	DISEASES inferred ¹³ GeneCards inferred via : Publications (show sections)

Variations for Breast Adenocarcinoma

Sources:
⁵Clinvar
See all MalaCards sources

Clinvar genetic disease variations for Breast Adenocarcinoma:

⁵

id	Gene	Variation	Type	Significance	SNP ID	Assembly	Location
1	PIK3CA	NM_006218.3(PIK3CA): c.3140A> G (p.His1047Arg)	SNV	Pathogenic	rs121913279	GRCh37	Chr 3, 178952085: 178952085
2	PIK3CA	NM_006218.3(PIK3CA): c.3140A> T (p.His1047Leu)	SNV	Pathogenic	rs121913279	GRCh37	Chr 3, 178952085: 178952085
3	PIK3CA	NM_006218.3(PIK3CA): c.1633G> A (p.Glu545Lys)	SNV	Pathogenic	rs104886003	GRCh37	Chr 3, 178936091: 178936091
4	AKT1	NM_005163.2(AKT1): c.49G> A (p.Glu17Lys)	SNV	Pathogenic	rs121434592	GRCh37	Chr 14, 105246551: 105246551

Expression for genes affiliated with Breast Adenocarcinoma

Sources:
¹⁸Gene Expression Omnibus DataSets
See all MalaCards sources

Search GEO for disease gene expression data for Breast Adenocarcinoma.

Pathways for genes affiliated with Breast Adenocarcinoma

Sources:
³⁴KEGG, ⁴²NCBI BioSystems Database, ⁵⁵PathCards, ⁵⁶PharmGKB, ⁵⁸QIAGEN, ⁵⁹R&D Systems, ⁶⁰Reactome, ⁶⁵Thomson Reuters, ⁶⁶Tocris Bioscience
See all MalaCards sources

Pathways related to Breast Adenocarcinoma according to GeneCards Suite gene sharing:

(show top 50) (show all 147)

id	Super pathways	Score	Top Affiliating Genes
1	Inhibition of Signaling by Overexpressed EGFR⁶⁰ Show member pathways Signaling by Overexpressed Wild-Type EGFR in Cancer⁶⁰	10.1	EGF, EGFR
2	E-cadherin signaling in keratinocytes⁴²	10.0	AKT1, EGFR, PIK3CA
3	AIF Pathway⁵⁸	10.0	CYCS, PARP1
4	Angiogenesis (WikiPathways)⁴² Show member pathways Angiogenesis⁴²	10.0	AKT1, MMP9, PIK3CA
5	CXCR4-mediated signaling events⁴²	10.0	AKT1, MMP9, PIK3CA
6	Signaling events mediated by TCPTP⁴²	10.0	EGF, EGFR, PIK3CA
7	Internalization of ErbB1⁴²	10.0	EGF, EGFR, PIK3CA
8	G-protein signaling_K-RAS regulation pathway⁶⁵	10.0	EGF, EGFR, PIK3CA
9	EGF receptor (ErbB1) signaling pathway⁴²	10.0	EGF, EGFR, PIK3CA
10	Thromboxane A2 receptor signaling⁴²	10.0	AKT1, EGF, EGFR
11	TSH signaling pathway⁴²	10.0	AKT1, FOS, PIK3CA
12	Nongenotropic Androgen signaling⁴²	10.0	AKT1, FOS, PIK3CA
13	TP53 network⁴² Show member pathways Activation, translocation and oligomerization of BAX⁶⁰	10.0	BAX, CDKN1A, TP53
14	Signaling events mediated by HDAC Class III⁴²	10.0	BAX, CDKN1A, TP53
15	14-3-3 and Regulation of BAD Activity⁵⁸	10.0	AKT1, BAX, TNF
16	Integrins in angiogenesis⁴²	10.0	AKT1, CASP8, PIK3CA
17	Celecoxib Pathway, Pharmacodynamics⁵⁶	9.9	AKT1, CDKN1A, MMP9
18	Development_TGF-beta receptor signaling⁶⁵	9.9	CDKN1A, ERBB2, TGFB1
19	Transcription Ligand-dependent activation of the ESR1/SP pathway⁶⁵ Show member pathways Development Ligand-dependent activation of the ESR1/AP-1 pathway⁶⁵	9.9	EGFR, ESR1, FOS
20	Longevity regulating pathway - multiple species³⁴ Show member pathways Regulation of lipolysis in adipocytes³⁴ Longevity regulating pathway³⁴	9.9	AKT1, BAX, PIK3CA, TP53
21	Thyroid hormone signaling pathway³⁴	9.9	AKT1, ESR1, PIK3CA, TP53
22	Cell adhesion_Plasmin signaling⁶⁵	9.9	PIK3CA, PLAU, TGFB1
23	Transcription_Role of VDR in regulation of genes involved in osteoporosis⁶⁵	9.9	FOS, TNF, TNFSF11
24	Signaling events mediated by PTP1B⁴²	9.8	AKT1, EGF, EGFR, PIK3CA
25	Plasma membrane estrogen receptor signaling⁴²	9.8	AKT1, ESR1, MMP9, PIK3CA
26	Epstein-Barr virus infection³⁴	9.8	AKT1, CDKN1A, PIK3CA, TP53
27	Signaling by PTK6⁶⁰ Show member pathways PTK6 Expression⁶⁰ PTK6 promotes HIF1A stabilization⁶⁰ PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases⁶⁰ PTK6 Activates STAT3⁶⁰ PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1⁶⁰ PTK6 Down-Regulation⁶⁰ PTK6 Regulates Proteins Involved in RNA Processing⁶⁰	9.8	AKT1, EGF, EGFR, ERBB2
28	Cell adhesion_ECM remodeling⁶⁵	9.8	EGFR, MMP9, PLAU
29	Estrogen signaling pathway⁴²	9.8	AKT1, ESR1, FOS, PIK3CA
30	VEGF Pathway (Tocris)⁶⁶ Show member pathways Sorafenib Pharmacodynamics⁵⁶ VEGF Pathway⁶⁶	9.8	AKT1, BAX, CASP8, PIK3CA
31	IL6-mediated signaling events⁴² Show member pathways IL-6 Signaling Pathway⁴²	9.8	AKT1, FOS, PIK3CA, TNFSF11
32	Small cell lung cancer³⁴	9.8	AKT1, CYCS, PIK3CA, TP53
33	p75(NTR)-mediated signaling⁴² Show member pathways Ceramide signalling⁶⁰ NFG and proNGF binds to p75NTR⁶⁰	9.8	AKT1, CYCS, PIK3CA, TP53
34	Direct p53 effectors⁴²	9.8	BAX, CDKN1A, EGFR, TP53
35	NGF Pathway⁵⁸ Show member pathways TRKA Signaling⁵⁸	9.8	AKT1, BAX, CYCS, TP53
36	UVA-Induced MAPK Signaling⁵⁸ Show member pathways UVB-Induced MAPK Signaling⁵⁸	9.8	AKT1, EGFR, FOS, TP53
37	Granzyme Pathway⁵⁸ Show member pathways Granzyme-B Pathway⁵⁸	9.8	CASP8, CYCS, PARP1
38	TGF-beta Signaling Pathways⁵⁹	9.8	AKT1, ESR1, FOS, TGFB1
39	VEGF Pathway (Qiagen)⁵⁸ Show member pathways VEGF Family Ligands and Receptor Interactions⁵⁸ VEGF Pathway⁵⁸ CCKBR-Gastrin Stimulated Signaling⁵⁸ Development VEGF-family signaling⁶⁵ Neurophilin interactions with VEGF and VEGFR⁶⁰	9.8	AKT1, EGF, EGFR, FOS
40	Legionellosis³⁴	9.8	CASP8, CYCS, TNF
41	Regulation of nuclear SMAD2/3 signaling⁴²	9.7	AKT1, CDKN1A, ESR1, FOS
42	LPA receptor mediated events⁴²	9.7	AKT1, EGFR, FOS, MMP9
43	S-1P Stimulated Signaling⁵⁸	9.7	AKT1, CASP8, EGF, EGFR
44	Gemtuzumab ozogamicin Pathway, Pharmacokinetics/Pharmacodynamics⁵⁶	9.7	AKT1, BAX, CYCS, PARP1
45	Corticotropin-releasing hormone⁴²	9.7	AKT1, FOS, PARP1, TGFB1
46	Central carbon metabolism in cancer³⁴	9.7	AKT1, EGFR, ERBB2, PIK3CA, TP53
47	Transcription_P53 signaling pathway⁶⁵	9.7	CDKN1A, FOS, TGFB1, TP53
48	MAPK Signaling: Oxidative Stress Pathway⁵⁹	9.7	BAX, CYCS, FOS, TP53
49	Cell cycle Role of SCF complex in cell cycle regulation⁶⁵ Show member pathways Cell cycle ESR1 regulation of G1/S transition⁶⁵ Cell cycle Regulation of G1/S transition (part 1)⁶⁵ Immune response MIF-JAB1 signaling⁶⁵	9.7	CDKN1A, ESR1, FOS, TGFB1
50	Signaling by ERBB2⁶⁰ Show member pathways GRB2 events in ERBB2 signaling⁶⁰ ERBB2 Regulates Cell Motility⁶⁰ Downregulation of ERBB2-ERBB3 signaling⁶⁰ SHC1 events in ERBB2 signaling⁶⁰ ERBB2 Activates PTK6 Signaling⁶⁰ PI3K events in ERBB2 signaling⁶⁰ PI3K events in ERBB4 signaling⁶⁰ SHC1 events in ERBB4 signaling⁶⁰	9.7	AKT1, EGF, EGFR, ERBB2, PIK3CA

GO Terms for genes affiliated with Breast Adenocarcinoma

Sources:
¹⁹Gene Ontology
See all MalaCards sources

Cellular components related to Breast Adenocarcinoma according to GeneCards Suite gene sharing:

id	Name	GO ID	Score	Top Affiliating Genes
1	extracellular space	GO:0005615	8.8	CTSK, EGF, EGFR, MMP9, PLAU, TGFB1

Biological processes related to Breast Adenocarcinoma according to GeneCards Suite gene sharing:

(show top 50) (show all 65)

id	Name	GO ID	Score	Top Affiliating Genes
1	positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle	GO:0031659	10.9	AKT1, EGFR
2	negative regulation of production of miRNAs involved in gene silencing by miRNA	GO:1903799	10.9	ESR1, TGFB1
3	positive regulation of histone deacetylation	GO:0031065	10.9	TGFB1, TP53
4	activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c	GO:0008635	10.9	BAX, CYCS
5	positive regulation of superoxide anion generation	GO:0032930	10.9	EGFR, TGFB1
6	positive regulation of mononuclear cell migration	GO:0071677	10.8	TGFB1, TNF
7	cellular response to epidermal growth factor stimulus	GO:0071364	10.8	AKT1, EGFR, ERBB2
8	positive regulation of programmed cell death	GO:0043068	10.8	CDKN1A, TNF
9	death-inducing signaling complex assembly	GO:0071550	10.8	CASP8, TNF
10	mammary gland alveolus development	GO:0060749	10.8	EGF, ESR1, TNFSF11
11	glucose metabolic process	GO:0006006	10.8	AKT1, PIK3CA, TNF
12	DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	GO:0006977	10.8	BAX, CDKN1A, TP53
13	positive regulation of epidermal growth factor receptor signaling pathway	GO:0045742	10.8	AKT1, ESR1, MMP9
14	positive regulation of release of cytochrome c from mitochondria	GO:0090200	10.7	BAX, MMP9, TP53
15	positive regulation of phosphorylation	GO:0042327	10.7	EGF, EGFR, TNFSF11
16	cellular response to ionizing radiation	GO:0071479	10.7	CDKN1A, TGFB1, TP53
17	positive regulation of protein localization to nucleus	GO:1900182	10.7	AKT1, PARP1, TGFB1
18	lipopolysaccharide-mediated signaling pathway	GO:0031663	10.7	AKT1, TGFB1, TNF
19	positive regulation of nitric oxide biosynthetic process	GO:0045429	10.7	AKT1, EGFR, TNF
20	apoptotic signaling pathway	GO:0097190	10.7	BAX, CASP8, TNF
21	regulation of cell motility	GO:2000145	10.7	EGF, EGFR, ERBB2
22	positive regulation of neuron apoptotic process	GO:0043525	10.6	BAX, NQO1, TP53
23	macrophage differentiation	GO:0030225	10.6	CASP8, MMP9, PARP1
24	positive regulation of osteoclast differentiation	GO:0045672	10.6	FOS, TNF, TNFSF11
25	protein import into nucleus, translocation	GO:0000060	10.6	AKT1, TGFB1, TNF
26	phosphatidylinositol phosphorylation	GO:0046854	10.6	EGF, EGFR, ERBB2, PIK3CA
27	cellular response to growth factor stimulus	GO:0071363	10.6	AKT1, EGFR, ERBB2, TGFB1
28	response to gamma radiation	GO:0010332	10.6	BAX, PARP1, TP53
29	epidermal growth factor receptor signaling pathway	GO:0007173	10.6	EGF, EGFR, PIK3CA, TGFB1
30	positive regulation of reactive oxygen species metabolic process	GO:2000379	10.6	CDKN1A, PLAU, TP53
31	positive regulation of epithelial cell proliferation	GO:0050679	10.6	EGFR, ERBB2, ESR1, TGFB1
32	response to corticosterone	GO:0051412	10.6	BAX, CDKN1A, FOS
33	positive regulation of peptidyl-serine phosphorylation	GO:0033138	10.6	AKT1, PIK3CA, TGFB1, TNF
34	positive regulation of sequence-specific DNA binding transcription factor activity	GO:0051091	10.5	AKT1, ESR1, TNF, TNFSF11
35	cellular response to mechanical stimulus	GO:0071260	10.5	AKT1, CASP8, EGFR, TGFB1
36	response to UV-A	GO:0070141	10.5	AKT1, EGFR
37	regulation of apoptotic process	GO:0042981	10.5	BAX, ESR1, TGFB1, TP53
38	positive regulation of fibroblast proliferation	GO:0048146	10.5	CDKN1A, EGFR, ESR1, TGFB1
39	intrinsic apoptotic signaling pathway	GO:0097193	10.5	BAX, CDKN1A, CYCS, TP53
40	ERBB2 signaling pathway	GO:0038128	10.5	AKT1, EGF, EGFR, ERBB2, PIK3CA
41	protein kinase B signaling	GO:0043491	10.5	AKT1, PIK3CA, TGFB1, TNF
42	positive regulation of protein kinase B signaling	GO:0051897	10.5	EGFR, TGFB1, TNF, TNFSF11
43	phosphatidylinositol-mediated signaling	GO:0048015	10.5	AKT1, EGF, EGFR, ERBB2, PIK3CA
44	cellular response to organic cyclic compound	GO:0071407	10.5	AKT1, CASP8, TGFB1, TNF
45	extrinsic apoptotic signaling pathway	GO:0097191	10.5	BAX, CASP8, TGFB1, TNF
46	cellular response to DNA damage stimulus	GO:0006974	10.4	AKT1, BAX, CDKN1A, PARP1, TP53
47	Sertoli cell proliferation	GO:0060011	10.4	BAX, ESR1
48	salivary gland morphogenesis	GO:0007435	10.4	EGFR, TGFB1
49	regulation of phosphatidylinositol 3-kinase signaling	GO:0014066	10.4	AKT1, EGF, EGFR, ERBB2, PIK3CA
50	MAPK cascade	GO:0000165	10.3	EGF, EGFR, ERBB2, TGFB1, TNF

Molecular functions related to Breast Adenocarcinoma according to GeneCards Suite gene sharing:

(show all 8)

id	Name	GO ID	Score	Top Affiliating Genes
1	nitric-oxide synthase regulator activity	GO:0030235	10.8	AKT1, EGFR, ESR1
2	phosphatidylinositol-4,5-bisphosphate 3-kinase activity	GO:0046934	10.7	EGF, EGFR, ERBB2, PIK3CA
3	protein phosphatase binding	GO:0019903	10.4	EGFR, ERBB2, TP53
4	enzyme binding	GO:0019899	10.3	AKT1, EGFR, ESR1, PARP1, TGFB1, TP53
5	protein heterodimerization activity	GO:0046982	10.0	BAX, EGFR, ERBB2, FOS, TGFB1, TP53
6	tumor necrosis factor receptor binding	GO:0005164	9.8	CASP8, TNF, TNFSF11
7	identical protein binding	GO:0042802	9.2	AKT1, BAX, CASP8, EGFR, ERBB2, ESR1
8	protein binding	GO:0005515	7.1	AKT1, BAX, CASP8, CDKN1A, CTSK, CYCS